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ABSTRACT OF THESIS 
 
 
APPETITE-REGULATING HORMONES 
IN ENERGY COMPENSATION WITH EXERCISE 
 
Background: The appetite-regulating hormones may influence compensatory increases 
in energy intake with exercise, although this causal relationship has been difficult to 
prove in a longitudinal trial. 
Methods: 37 participants (29 female) aged 18 to 40 years performed aerobic exercise 6 
days (6d), 2 days (2d), or 0 days per week for 12-weeks. Concentrations of ghrelin, 
leptin, glucagon-like peptide 1 (GLP-1), and insulin were assessed before (fasting, 
minute 0) and after a standardized meal at minute 15, 30, 45, 60, 90, 120, 150, and 180. 
Linear mixed-effects models were used to model the relationships between time point 
(12 weeks vs. baseline) and group over time (minutes 0 to 180) for each hormone. For 
2d and 6d, the total area under the curve (AUC) for post-prandial hormone changes from 
pre-intervention to post was calculated and used to predict % body fat lost and energy 
compensation, defined as the difference between expected weight loss (based on 
exercise energy expenditure, ExEE) and changes in bodily energy stores. Energy 
compensation was expressed as % energy compensated (compensation index, CI). 
Results: The 2d and 6d expended 1,490.7 ± 122.1 and 2,750.5 ± 145.1 kcal while 
exercising 188.8 ± 4.12 and 320.5 ± 3.7 min/week respectively (means ± SE, P<0.01). 
CI did not differ between 2d and 6d (P=0.81), averaging 52%. Only 6d lost significant 
body fat (-7.29% ± 2.13 vs -1.86% ± 4.12, P=0.03). For the mixed-effects model, ghrelin 
(P=0.03) and leptin (P<0.01) had significant group by time interactions, decreasing to a 
greater extent in 6d than 2d or control. Changes in AUC for ghrelin (delta-AUC) 
predicted the percentage of fat loss controlling for CI and ExEE while changes in AUC 
for leptin predicted CI controlling for ExEE and fat loss. 
Conclusion: The 12-week changes in ghrelin and leptin are influenced by exercise 
frequency in overweight to obese adults. Greater decreases in ghrelin delta-AUC are an 
independent predictor of body fat loss attenuation, while greater leptin delta-AUC 
decreases are an independent predictor of CI. These findings represent a novel 
predictor of energy compensation and body fat loss with exercise. 
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CHAPTER 1. Introduction 
1.1 Background 
Overweight (Body Mass Index [BMI] 25.0-29.9) and obesity (BMI ≥ 30.0) is a 
growing epidemic, with over 70% of the United States population classified as 
overweight or obese [1-4]. Obesity is a well-known risk factor in developing severe 
comorbidities such as heart disease, type 2 diabetes, fatty liver disease, and certain 
types of cancers, leading to early mortality [1, 2, 5]. The underlying cause of obesity is 
excessive weight gain through excessive energy intake and/or insufficient energy 
expenditure [5-7]. Energy intake has been observed to be influenced by physiological, 
genetic, environmental, and social factors. However, recent literature has demonstrated 
that physiological factors have the most significant impact [8, 9]. 
A commonly used obesity treatment strategy is exercise, increasing energy 
expenditure to favor a negative energy balance. However, exercise may also influence 
certain physiological factors, such as hormonal mediators of hunger, causing increases 
in energy intake; therefore, compensating for energy expended through exercise to 
resist desired weight loss. 
1.2 Problem Statement 
Many long-term and acute studies have investigated how different types of 
variables of an exercise program affect the concentrations of the appetite-regulating 
hormones and energy intake; however, the amount of research investigating the long-
term consequence of these hormonal alterations is little to none [10-17]. Therefore, 
investigating the effect of exercise frequency on appetite-regulating hormones and 
determining how these hormonal changes influence the compensatory response to 
exercise is a crucial need for determining how exercise can be used most effectively to 
promote weight control. 
2 
1.3 Research Questions 
1. Does aerobic exercise frequency, after a 12-week intervention, influence 
postprandial changes in plasma acylated ghrelin, leptin, GLP-1, and insulin 
concentrations? 
2. Can identifying hormonal changes and their influence on compensatory 
responses to exercise determine which variables predict sufficient weight loss? 
 
1.4 Hypothesis 
1. Ghrelin concentrations will increase while leptin and GLP-1 
concentrations will decrease in response to a meal to a greater extent when 
engaging in 6 weekly aerobic exercise sessions compared to 2 sessions after 12 
weeks. 
2. Changes in hunger hormones after 12 weeks of exercise will predict body 
fat loss, with changes in Ghrelin being negatively associated with body fat loss 
and Leptin, GLP-1, and insulin being positively associated with body fat loss. 
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CHAPTER 2. Literature Review 
2.1 Introduction 
America is among the countries with the most significant overweight and obesity 
rates, with rates continually rising [2, 3]. 70.9% of men and 61.9% of women are deemed 
overweight (Body Mass Index [BMI] 25.0-29.9 kg/m²) or obese (BMI ≥ 30.0 kg/m²), 
compared to 38% of men and 36.9% of women in all other countries [2, 3]. BMI is highly 
correlated with adiposity and the development of comorbidities such as cardiovascular 
disease, type 2 diabetes, fatty liver disease, and certain cancers [1, 5, 6, 18]. 
Adiposity begins with the amount of energy intake being more than the amount 
energy expended [5, 6]. Energy intake is complex and controlled by many different 
physiological, behavioral, psychological, and environmental factors [5, 7]. These factors 
contribute to the imbalance between energy intake and expenditure among overweight 
and obese individuals [2, 8]. Specific physiological factors include alterations in appetite-
regulating hormones, posited to influence energy intake significantly [8, 9]. 
It is well-known that a diet-induced energy deficit can result in a negative energy 
balance and weight loss [1, 19]. Among overweight to obese individuals, diet-induced 
energy deficits are difficult to maintain due to changes in concentrations of appetite-
regulating hormones functioning to increase sensations of appetite cues [1, 6, 19]. This 
makes it extremely difficult to maintain significant weight loss. Exercise training is 
another means for weight loss many individuals use, increasing energy expenditure to 
promote a negative energy balance (known as exercise training-induced energy deficit) 
[9-11, 16, 19-24]. Many acute/short- and long-term studies have investigated how an 
exercise training-induced energy deficit may influence these hormones, with many 
offering conflicting results [10-17, 21, 25-28]. Specific characteristics and behaviors such 
as sex, body adiposity, and diet may contribute to the varying effects exercise has on 
fasting- and postprandial concentrations of appetite-regulating hormones [10, 29-32]. 
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Furthermore, the effects of different modes and frequencies of exercise on appetite-
regulating hormone concentrations are not thoroughly understood, making it difficult for 
health care professionals to prescribe the most effective exercise training program for 
overweight to obese men and women [10, 12, 13, 15, 25, 28, 33]. The purpose of this 
review is to investigate factors that can influence fasting and postprandial concentrations 
of the appetite-regulating hormones, including the attributes of an exercise program. 
2.2 Physiology of Hunger and Satiety Inducing Hormones 
Appetite regulation is primarily driven by peptide hormone control, operating at the 
brain, gut, and peripheral regions [8, 9, 34, 35]. These appetite-regulating agents 
administer different inputs and signals from these regions that interact with various brain 
systems [8, 35]. This includes the brainstem that receives neuronal inputs from the 
digestive tract and the hypothalamus, which receives hormonal and nutritional signals 
from peripheral blood circulation [8, 9, 35]. These signals are received directly by 
neurons on the arcuate nucleus (ARC), a particular segment of the hypothalamus, 
through the blood-brain barrier [8, 9, 34, 35]. Together, these systems collect information 
about the body’s nutrient status and respond accordingly by controlling sensations of 
hunger and satiety, influencing energy intake, and often playing a role in body weight 
regulation [8, 9, 34, 35]. 
2.2.1 Appetite-Regulating Neurons of The Hypothalamus 
Within the ARC, there are two classes of neurons that run adjacent to one 
another: 1) the appetite-inhibiting neurons expressing pro-opiomelanocortin (POMC) and 
cocaine- and amphetamine-regulated transcript (CART), and 2) the appetite-stimulating 
neurons expressing neuropeptide Y (NPY) and agouti-related peptide (AgRP) [18, 35-
37]. Stimulation of the POMC-CART neurons will deactivate the hypothalamic feeding 
centers, decreasing appetite or feeding behavior [8, 36, 38]. Notably, POMC reduces 
appetite by releasing the neurotransmitter alpha-melanocyte-stimulating hormone (a-
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MSH) [8, 36, 38]. A-MSH binds to the melanocortin-4 receptor (MC4-R) on the 
paraventricular nucleus (PVN) [8, 36, 38, 39]. In response, PVN projects the stimulus to 
other sites through the brain coordinating energy homeostasis [8, 30, 35]. This makes 
MC4-R the critical receptor for appetite control and energy homeostasis [8, 36, 38]. The 
other appetite-inhibiting neuron, CART, has been associated with sensory processing, 
with decreased expression observed in food deprivation [8, 36]. Activation of both POMC 
and CART is through the renowned anorexigenic hormone, leptin [40, 41]. 
2.2.2 Leptin 
Leptin is a cytokine synthesized and released from adipocytes in response to 
changes in energy stores and systemic energy balance [8, 18, 40, 41]. The main action 
of leptin is to stimulate satiety while simultaneously inhibiting appetite [8, 18]. Leptin 
circulates partially bound to plasma proteins, with concentrations proportional to the 
degree of adiposity, and enters the ARC by diffusion [8, 18, 40]. The receptor of leptin 
associated with energy homeostasis, secretory organs’ regulation, and innate and 
adaptive immunity is found in the hypothalamus and defined as Ob-Rb.[8, 18, 40-42] 
This receptor is a type I cytokine receptor and is encoded by the LEPR gene in humans 
[42]. Ob-Rb is present at multiple hypothalamus sites, such as the ARC and PVN [35, 
40]. The expression of the Ob-Rb receptor is in many different forms [40]. These forms 
include the long-form, which is necessary for the action of leptin on appetite, and the 
short form, which plays a role in transporting leptin across the blood-brain barrier [40]. 
The Ob-Rb receptor plays a significant role in early obesity development when a lack of 
the receptor is expressed [40]. Leptin stimulates satiety is through POMC-CART 
activation upon binding to the leptin receptor located on the ARC [8, 40]. Leptin’s 
additional role of attenuating appetite is through NPY and AgRP activation upon binding 
to NPY-G-protein-coupled receptors and melanocortin receptors located on ARC [8, 40]. 
Other leptin effects include increased insulin sensitivity through decreasing intracellular 
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lipid levels in skeletal muscle, liver, and pancreatic beta cells [41]. Since leptin's level of 
secretion depends on adiposity, individuals with obesity typically have greater leptin 
concentrations than lean counterparts [40, 41]. However, leptin resistance is often 
experienced in obesity, mediated by leptin signaling inhibition [40, 41]. Leptin resistance 
facilitates the sensation of hunger and leads to increased energy intake among 
individuals with obesity [8]. Normal regulation of leptin in neurons of the ARC not only 
stimulates POMC-CART activation but inhibits the appetite-stimulating neurons, NPY, 
and AgRP [8, 18, 40-42]. 
2.2.3 NPY and AgRP 
Throughout the ARC to the PVN and other hypothalamic sites, NPY neurons' are 
expressed [36, 37]. NPY is one of the most abundant neuropeptides and most potent 
orexigenic factors [8]. These neurons are inhibited by leptin and insulin while stimulated 
by glucocorticoids and ghrelin [8, 36, 37]. The main physiological action of NPY is 
appetite stimulation through the NPY-G-protein-coupled receptors Y1 and Y5 (Y1R/Y5R) 
[8, 30, 36, 37]. Additionally, NPY represses the satiety stimulation effect of a-MSH by 
producing AgRP signaling proteins [36]. AgRP is a ligand of the melanocortin receptor 
subtypes MC3-R and MC4-R [8, 18, 30]. When AgRP binds, it represses a-MSH 
production by blocking its receptor MC1-R [8, 39]. Primarily, signal activation of both 
NPY and AgRP is through the well-known appetite stimulant ghrelin [8, 37]. 
2.2.4 Ghrelin 
Ghrelin, or growth hormone (GH)-releasing peptide, is the single peripheral 
peptide known to increase appetite [8]. Ghrelin directly stimulates the expression of 
neurons NPY and AgRP in the ARC, consequently stimulating food intake [43]. Ghrelin 
also promotes food intake due to its antagonizing effect on leptin, as ghrelin and leptin 
compete for neuron interaction stimulating or inhibiting NPY [8]. Ghrelin is mainly 
produced in the stomach by the endocrine cells of the fundus' gastric mucosa [8, 9, 44]. 
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Ghrelin is also an endogenous ligand for the growth hormone secretagogue-receptor 
type 1a (GHS-R1a) [8, 9, 44]. Several central nervous system (CNS) areas involved in 
energy intake regulation, such as the mesolimbic dopaminergic system, dorsal vagal 
complex, and the hypothalamic nuclei express GHS-R1a [8, 9, 44]. Besides appetite 
stimulation, ghrelin has multiple effects such as GH, acetylcholine (ACTH), cortisol, 
aldosterone, catecholamine, and prolactin secretion [8, 9, 44]. High ghrelin levels are 
typically observed in the fasted state, which falls following meals [45, 46]. Ghrelin levels 
are inversely correlated with adiposity and are slower postprandial decline among 
overweight or obese [8, 47, 48]. This slower postprandial drop in ghrelin impairs meal-
induced satiety, predisposing individuals with greater adiposity to greater energy intake 
and potentially weight gain [45, 47, 48]. In contrast, peripheral peptides that are 
associated with satiety, in addition to leptin, include cholecystokinin (CCK), peptide YY 
(PYY), glucagon-like peptide-1 (GLP-1), and insulin [8, 9, 18]. 
2.2.5 CCK 
The satiety inducing peptide hormone CCK is found extensively in the brain and 
GI tract and was one of the first peptides discovered inside the gut in 1943 [49]. CCK 
plays numerous physiological and neurological roles such as mediating digestion in the 
small intestine through inhibiting gastric emptying, stimulating digestive enzyme release 
in the pancreas, and stimulating gall bladder contraction and sphincter of Oddi 
relaxation, which increases production and delivery of bile [8, 9, 18, 50, 51]. CCK also 
mediates satiety through acting on CCK receptors in the CNS [8, 51, 52]. CCK is 
produced and released by enteroendocrine cells in the mucosal lining of the duodenum 
and jejunum (I cell, IC), and neurons in the enteric nervous system (ENS) and brain [8, 
9, 18, 50, 51]. The stimulation of CCK release is primarily by fatty acids (FA) or specific 
amino acids (AA) present in the chyme [8, 9, 18, 50, 51]. Other modes of CCK activation 
include monitor peptide, CCK-releasing protein, and acetylcholine [8, 9, 18, 50, 51]. 
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Other means of CCK inhibition include somatostatin (growth hormone-inhibiting 
hormone), pancreatic peptide (PP), and trypsin (a pancreatic enzyme) [8, 9, 18, 50, 51]. 
There are many different forms of CCK; however, all forms bind to two distinct receptors: 
CCK-A and CCK-B [8, 9, 18, 50, 51]. CCK-A is primarily located on vagal afferent and 
enteric neurons in the pancreas with smaller amounts in the CNS and is mainly 
responsible for sensations of satiety and inhibiting food intake [51]. To activate CCK-A 
receptors, they require binding of sulfated tyrosine moiety of CCK-8 and CCK-33; these 
forms have a high affinity for the CCK-A receptor [50, 51]. CCK-B is primarily found in 
the CNS and does not affect food intake [50, 51]. Activation of CCK-B requires gastrin, 
de-sulfated CCK, and CCK-4 (a CCK fragment) binding to activate; these forms have a 
high affinity for the CCK-B receptor but low affinity for the CCK-A receptor [50, 51]. 
Intraperitoneally (IP) administered CCK can inhibit food intake by reducing meal size and 
duration [52]. However, since CCK’s half-life is short (1-2 minutes), IP injection is most 
effective immediately before a meal [8, 52]. CCK concentrations gradually increase over 
10-30 minutes after meal initiation due to specific nutrients in the gut, primarily fat and 
protein, and remain elevated for up to 5 hours [8]. In bodyweight regulation, CCK plays 
an important role and may act synergistically with leptin, whereas leptin potentiates the 
magnitude of feeding suppression signals produced by CCK [9, 51]. CCK-A deficiency 
can, therefore, increase the development of obesity due to decreasing the binding of 
CCK, resulting in decreased food reduction signals, leading to increased food intake and 
weight gain [8, 9, 49, 51]. 
2.2.6 PYY 
PYY, a gut-derived hormone, is produced by the intestinal L cells of the ileum, 
colon, and rectum and secreted postprandially [8, 9, 18]. Postprandial concentrations of 
PYY are proportional to the meal macronutrient content, with higher levels observed 
after a high-fat meal than a high carbohydrate and protein meal [8]. Peripheral circulation 
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of PYY exists in two forms: PYY1-36 and PYY3-36, with PYY3-36 as the peripherally active 
anorectic signal [8, 9, 18]. PYY3-36 is formed by cleavage of the N-terminal Tyr-Pro 
residues by dipeptidyl peptidase IV (DPP-IV) and binds to Y2 receptors (Y2R) to inhibit 
NPY neurons and stimulate POMC neurons [8, 9, 18]. The Y2R is a putative inhibitory 
pre-synaptic receptor and is part of the Y family of G-protein coupled receptors [8, 9, 18]. 
These receptors are highly expressed on the NPY neuron in the ARC but not on POMC 
neurons [9]. Binding of the Y2R agonist, PYY3-36, to its receptors, Y2R, stimulates 
appetite inhibition by decreasing food intake sustained for 24-hrs  [53, 54]. IP and intra-
ARC (I-ARC) injection of PYY3-36  in obese and normal-weight individuals expresses 
these appetite inhibition effects [53, 55]. Administered PYY3-36 in the peritoneum and I-
ARC can also reduce weight gain; however, PYY can also have appetite-stimulating 
effects [8, 9, 18, 53]. For instance, administered PYY3-36 in the intracerebroventricular 
vein (ICV) stimulates food intake by binding the Y1R and Y5R in the PVN [55]. Y1R and 
Y5R are also targeted by the orexigenic ARC NPY neurons, which increase appetite [8, 
9, 18]. This hormone plays a significant role in appetite and weight regulation by 
reducing energy intake and body weight gain when injected through the IP and I-ARC; 
therefore, it is an essential appetite-regulating hormone to observe among obese and 
overweight individuals [56]. Obese individuals can develop PYY deficiency due to a 
lower endogenous PYY response after each meal than normal-weight individuals [8, 56]. 
PYY deficiency can alter appetite and weight gain regulation, thus reinforcing obesity [8, 
56]. 
2.2.7 GLP-1 
Another appetite-regulating peptide hormone that is 30 or 31 amino acids long 
and derived from posttranslational processing of proglucagon is known as GLP-1 [8, 9, 
18, 30, 57-61]. Activation of the proglucagon's posttranslational process includes 
expression of the proglucagon gene, and transcription and cleavage of proglucagon 
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must occur [57-61]. Several organs express this gene, such as the alpha-cells (a-cells) 
of the pancreas, intestinal enteroendocrine L-cells of the gut (specialized cells of the GI 
tract/pancreas with endocrine function), and the caudal brainstem and hypothalamus 
within the brain [8, 9, 18, 30, 57-61]. Within the a-cells of the pancreas, proglucagon is 
cleaved and transcribed by site-specific prohormone convertase 2 (PC2), which 
generates the active glucagon, glicentin-related polypeptide (GRPP), intervening peptide 
1 (IP1), and major proglucagon fragment (derived from GLP-1, IP2, and GLP-2; Figure 
1) [57, 61]. Within the intestinal enteroendocrine L-cells of the intestine, primarily the 
jejunum/duodenum, the caudal brainstem, and hypothalamus, proglucagon is catalyzed 
by PC1/3 to form glicentin formed by GRPP, glucagon, and IP1 [57, 59, 61]. Additional 
products of processing glicentin include GRPP, oxyntomodulin (derived from 
glucagon/IP1), IP2, GLP-1, or GLP-2 [57, 59, 61]. Along with oxyntomodulin and other 
peptide hormones, GLP-1 is an incretin [59]. Incretins can enhance glucose-stimulated 
insulin secretion by decreasing blood glucose levels in a glucose-dependent manner 
[59]. GLP-1 is converted into two circulating bioactive forms, GLP17-36 amide and GLP17-
37 [57, 61]. GLP17-36 accounts for about 20% of active GLP-1, whereas GLP17-37 is the 
most abundant form and accounts for about >80% [57, 61]. GLP11-37  is first catalyzed by 
endopeptidase to GLP17-37 [57, 61]. Next, GLP17-36  is amidated by the glycine terminal 
AA, which serves as a substrate for C-terminal arginine, producing the active GLP17-36 
[57, 61]. After the bioactive forms are released, they are rapidly degraded by dipeptidyl 
peptidase (DPP)-4 to GLP19-36 or GLP19-37; thus, explaining why GLP-1 has a short 
half-life (1-2 minutes) in blood circulation [8, 57, 61]. GLP-1 has various physiological 
functions in the gut, brain, and pancreas [8, 9, 18]. GLP-1 in the gut inhibits gastric 
emptying, acid secretion, and motility, which collectively result in decreased appetite [8, 
9, 18]. In the brain, GLP-1 has correlated with neurotrophic (neurogenesis) and 
neuroprotective (necrotic/apoptotic signaling and cell death reduction) effects [61]. 
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Within regions of the brain such as the brainstem and hypothalamus, GLP-1 activates 
certain neurons in the ARC and PVN, the solitary tract's nucleus, and area postrema that 
lead to decreased appetite [61]. Looking at the pancreas, the most notable ability of 
GLP-1 is promoting insulin secretion through a glucose-dependent manner, inhibiting 
glucagon secretion, and replenishing beta-cell insulin stores during secretion [57, 61]. 
GLP-1 replenishes beta-cell insulin stores by promoting insulin gene transcription, 
mRNA stability, and mRNA biosynthesis [57, 61]. The binding of GLP-1 initiates these 
actions to its receptor, which is a G-protein coupled receptor [57, 61]. Many tissues such 
as pancreatic islet cells, lung, heart, kidney, stomach, intestine, pituitary, skin, vagus 
nerve, and certain CNS regions such as the brainstem and hypothalamus express the 
GLP-1 receptor (GLP-1R) [8]. Effects of ICV and IP administration of GLP-1R agonists 
(exenatide, lixisenatide, liraglutide) are consistently associated with decreased food 
intake and weight loss, whereas effects of ICV and IP administration of GLP-1R 
antagonists (NPY, exendin9-39) include increased food intake weight gain [57, 62]. 
Figure 1 below describes the physiological mechanisms of GLP-1 production.  
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Figure 1. Products of pre-proglucagon cleavage Numbers (#→#) denote amino acid 
residues at which cleave occurs. GRPP; Glicentin-related pancreatic polypeptide, 
MPGF; Major pro-glucagon fragment.  
Pro-glucagon
Products:
GRPP
1→ 30
► Glucagon
33 → 61
► IP−1
64 → 69
► GLP−1
72 → 107/108
► IP−2
111 → 123
Brain & 
Gut
Glicentin
GRPP
Oxyntomodulin
IP-2 GLP-1 GLP-2
Pancreas
GRPP
Glucagon
IP-1
MPGF
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2.2.8 Insulin 
Lastly, another critical hormonal regulator of appetite and the first peptide 
hormone discovered is the anabolic hormone insulin [8, 9, 18, 30]. Insulin has various 
metabolism and appetite regulation roles; weight control; insulin also has a lipo-static 
role similar to leptin [8, 9]. Like leptin, circulating insulin levels are proportional to the 
degree of adiposity [8, 9]. Insulin has a half-life of approximately 4-6 minutes, and levels 
increase rapidly after meal consumption [57]. ICV administered insulin reduces food 
intake and body weight due to insulin receptors being highly concentrated and widely 
distributed in the brain [62]. These effects are initiated primarily by the ARC by inhibiting 
the NPY/AgRP neurons [59, 61, 62]. In circulation, insulin is produced and released by 
the endocrine pancreas' beta cells and degraded within one hour [59, 61, 62]. Blood 
circulation release of insulin can be stimulated by metabolic signals and vagal nerve 
stimulation and inhibited by specific metabolic signals, epinephrine, and somatostatin [9, 
59, 61, 62]. The effects of insulin are activated from receptor binding, with the receptor 
found in the cell membrane [8, 9, 18, 30]. When insulin binds to the receptor, it triggers 
the B subunits' autophosphorylation, molecules inside the receptor, and subsequently, 
the phosphorylation of the insulin receptor substrates (IRS), which are proteins found 
inside the cell [8, 57, 59]. Expressed IRS in neurons with appetite-regulating and weight 
control effects consist of only two: IRS-1 and IRS-2 [8, 57, 59]. Increased food intake, 
adiposity, and plasma leptin levels have been demonstrated when neuron-specific 
disruption of the insulin receptor gene occurs [41]. Specifically, removing IRS-2 causes 
increased food intake and adiposity [41]. When describing the effects of insulin, 
interpretation is analogous to leptin [8, 9, 18, 41]. Through the adipo-insular axis, insulin 
can stimulate leptin synthesis and secretion from white adipose tissue [8, 9, 18, 41]. The 
relationship between insulin and leptin is typical in hypothalamic targets and common 
signal transduction pathways in the pancreas, muscles, and liver [8, 9, 18, 41].Table 1 
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shown below describes the physiological characteristics of the appetite-regulating 
hormones.  
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Table 1. Overview of the physiological mechanisms in correspondence to the 
appetite-regulating hormones. 
Region Hormone/Peptide Primary Production Site Receptor(s) 
Effect on 
Appetite Other Action(s) 
 
Hunger 
 
Brain NPY Medial ARC and other 
hypothalamic sites 
Y1, Y5 Increase Antagonizing 
POMC actions 
Peripheral Ghrelin Stomach (endocrine cells 
of the gastric mucosa of 
the fundus) 
GHS-R1a Increase Stimulates 
expression of 
NPY/AgRP, 
release of GH and 
other pituitary 
hormones, gastric 
motility, 
pancreatic 
polypeptide (PP) 
release 
 
Satiety 
 
Brain POMC/a-
MSH 
ARC MC3-R, MC4-R Decrease Stimulates basal 
metabolic rate 
Peripheral CCK I-cells of duodenum, 
jejunum; widespread CNS 
expression 
CCK-A, CCK-B Decrease Stimulates 
pancreatic 
secretion, gall 
bladder 
contraction, 
intestinal motility. 
Inhibits gastric 
motility 
Peripheral PYY L-cells of distal small/larger 
intestine; immunoreactivity 
in hypothalamus, medulla 
Y2 Decrease Inhibits 
gallbladder 
secretion, gut 
motility, 
pancreatic 
secretion 
Peripheral GLP-1 L-cells of distal small/large 
intestine; immunoreactivity 
in hypothalamus, 
dorsovagal complex, 
pituitary 
GLP-1 receptor Decrease Promotes 
pancreatic B-cell 
growth. 
Inhibits glucagon 
release, gastric 
emptying, and 
secretion 
Peripheral Insulin Beta cells of the endocrine 
pancreas 
Insulin receptor Decrease Various roles in 
metabolism 
Peripheral Leptin Adipose tissue Leptin receptor 
(Ob-Rb) 
Decrease Stimulates 
POMC-CART, 
increase insulin 
sensitivity 
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2.3 Appetite-Related Hormones in The Development of Obesity 
2.3.1 Heterogeneity of Fasting and Postprandial Concentrations of Appetite-Regulating 
Hormones 
Many clinical trials investigate the effects exercise has on fasting and 
postprandial concentrations of appetite-regulating hormones [10, 12, 13, 27]. However, 
various findings are observed among these studies due to the heterogeneity in 
methodologies and outcome measures [10, 12]. For example, different sex, body 
adiposity, and diet are factors that can yield differentiating effects in appetite-regulating 
hormone concentrations in response to exercise [12]. Thus, considering differences in 
these variables is essential when concluding exercise for weight control interventions. 
The findings of many exercise for weight control studies that do not monitor sex, body 
adiposity, and diet differences are varied, limited, and call for further research to be 
conducted [10, 12, 13, 21, 25, 27, 28]. Inversely, studies that do monitor sex, body 
adiposity, and diet conclude equivocal findings of these characteristics and behaviors on 
appetite-regulating hormone responses to acute (after a single exercise bout) or chronic 
/ long-terms exercise interventions [12]. To further understand the influence sex has on 
appetite responses to different types of exercise, recent studies that monitor these 
characteristics and behaviors will be examined and discussed. 
2.3.2 Sex 
Taking sex differences into account during exercise for weight loss interventions 
would minimize varied findings/results and improve understanding of the unknown 
mechanisms that influence appetite with exercise. In the physiology of appetite and 
energy intake, females and males have different activation and organization effects of 
reproductive hormones (androgens & estrogens) [63]. The relatively permanent effects 
of gonadal steroid hormones in early development or puberty are the organizational 
effects [63]. Activation effects are relatively reversible effects at other life stages and 
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require anatomic substrates in early development by sexually differentiated 
organizational processes [63]. These reproductive hormones can influence many 
mechanisms of appetite and energy intake [12, 63]. However, studies that analyze 
exercise-induced changes in appetite-regulating hormones generally feature mostly 
males participants [12]. Males in exercise and appetite research typically relate to 
cyclical changes in reproductive hormones, whereas different phases of the menstrual 
cycle in females influence the action of appetite-regulating hormones [64]. For example, 
energy intake, plasma GLP-1, and insulin are suppressed during the follicular phase, 
and total PYY concentrations are lower during the luteal phase of the menstrual cycle 
[64, 65]. Research on exercise and appetite has recently focused on appetite changes 
after exercise in females, suggesting that females compensate more for exercise-
induced energy deficits over more extended periods to preserve more body adiposity 
than males [66].  
Designated in Table 2, the purpose of this section is to discuss and consolidate 
recent findings of the modulating effects of sex on concentrations of appetite-regulating 
hormones with exercise-induced weight-loss interventions. 
2.3.2.1 Acute Exercise 
Comparisons of acute exercise-induced changes in appetite-regulating hormones 
between females and males demonstrate that both sexes have similar changes in 
appetite-stimulating responses [67-70]. It is essential to discuss that the female subjects 
completed all trials in the follicular phase of the menstrual cycle within these studies, 
which helped minimize the confounding effects on the measured appetite-regulating 
hormones [67-70]. Effects of a single bout of vigorous-intensity exercise (70% VO2 peak) 
on the appetite-stimulating hormone, acylated ghrelin, was suppressed in females and 
males [67, 68, 71]. However, the effects of sex on the appetite-inhibiting hormones are 
less conclusive [68-71]. For example, Panissa et al. reported no effect of exercise on 
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PYY3-36, while Hagobian et al. indicated that PYY3-36 concentrations were increased after 
exercise in only females [68, 71]. Hazell et al. also found elevations in total GLP-1 
concentrations after moderate-intensity cycling (65% VO2 peak) and sprint interval 
cycling in only females  [69]. Hazell et al. also found that total GLP-1 concentrations 
were elevated after moderate-intensity cycling (65% VO2 peak) and sprint interval 
cycling in only females [69]. However, Shamlan et al. demonstrated that total GLP-1 
concentrations were not affected by high-intensity intermittent or continuous low-intensity 
cycling in females and males [70]. Due to the differentiating results in the literature, it is 
difficult to conclude whether sex affects appetite-suppressing hormones in acute 
exercise [67, 68, 70-72]. 
2.3.2.2 Chronic Exercise 
Few studies have directly examined potential sex differences within the appetite-
regulating hormones in response to chronic exercise [12]. Some report fasting leptin and 
insulin concentrations are significantly reduced after a 12-week exercise intervention in 
only females [73]. Similarly, after a four-day exercise intervention fasting leptin and 
insulin concentrations are reduced [74]. In contrast, more significant reductions in insulin 
and a greater elevation in acylated ghrelin were observed postprandially in overweight 
and obese females than males, although findings reported no differences in fasting leptin 
changes between females and males [74]. These studies' findings support the 
suggestion that changes in the appetite-regulating hormones in response to exercise-
induced energy deficits are divergent in females compared to males [74]. However, due 
to the insufficient amount of conducted research that observes how sex influences the 
appetite-regulating hormones in response to chronic exercise, more exercise training 
intervention studies need to be conducted before making a decisive conclusion [12].  
Furthermore, most studies utilize aerobic exercise training interventions [12]. Thus, the 
literature findings are restricted; therefore, conducting more research will investigate 
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potential sex differences in the appetite-regulating hormones with other exercise 
modalities that may differ in duration and intensity.  
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Table 2. Overview of articles that analyzed the modulating effects of sex on 
concentrations of appetite-regulating hormones with exercise. 
Source Study Details 
Type of 
Exercise 
(Mode/Intensity) 
Study Population Key Findings 
 
Acute Exercise 
 
Alajmi et 
al. [67] 
Experiment 1: N = 12, three 9-hr 
trials (control, exercise-induced 
[Ex-Def], food restriction-induced 
energy deficit [Food-Def]), identical 
energy deficits imposed in Ex-Def 
& Food-Def trials, compared 
appetite/energy intake/acylated 
ghrelin/PYY3−36 responses to an 
equivalent energy deficit induced 
by exercise or energy restriction 
 
Experiment 2: N = 20, Two 7-hr 
trials (Control & Exercise), 60 
minutes of running performed at 
beginning of exercise trial, directly 
compared appetite/food 
intake/circulating acylated ghrelin 
responses to an exercise-induced 
energy deficit in men vs. women 
Experiment 1: 
 
90 minutes of 
running (~70% 
VO2 max) 
 
Experiment 2: 
 
60 minutes of 
running (~70% 
VO2 max) 
Experiment 1: 
 
Women, ~22.4 
years, BMI ~22.0 
 
Experiment 2: 
 
Men (aged ~22.6 
years) & women 
(aged ~22.3 
years), BMI ~22.4-
23.1 
Women exhibit 
compensatory 
appetite/gut 
hormone/food intake 
responses to acute 
energy restriction but 
no in response to 
acute bout of exercise; 
Men & women exhibit 
similar acylated 
ghrelin/PYY3−36 
responses to exercise-
induced energy 
deficits 
 
 
Panissa et 
al. [71] 
N = 20, compare the effects of 
exercise intensity on appetite 
control: relative energy 
intake/hunger scores/appetite-
regulating hormones, completed 6 
session (2 screening/4 
experimental) separated by at least 
72-hr and a maximum of 1-wk for 
men; Randomized crossover 
design  
High-intensity 
intermittent all-
out exercise 
(HIIE-A) for 60 x 
8 seconds 
interspersed by 
12 seconds of 
passive 
recovery/High-
intensity 
intermittent 
exercise (HIIE) at 
100% of maximal 
load attained in 
incremental 
test/Steady-state 
exercise at 60% 
of maximal load 
(matched by work 
done)/Control 
session 
Men (n=11) & 
women (n=9), 
aged 27 ± 3 years, 
physically active  
None of exercise 
protocols generated a 
compensatory 
increase in energy 
intake in men/women; 
Acylated 
ghrelin/hunger 
perception were more 
suppressed and 
cortisol/insulin were 
more elevated in the 
HIIE-A compared with 
the control; 
Regardless of sex, 
Appetite hormones did 
not have a major 
impact on acute 
energy intake 
Hagobian 
et al. [68] 
N = 21, find whether acute exercise 
suppresses relative energy intake 
in both men/women exposed to 
same relative exercise treatment, 
Rested for 60 minutes or exercised 
on a cycle ergometer (~70% 
VO2 max) until 30% of total daily 
energy expenditure was expended; 
Counterbalanced/crossover design 
Rested for 60 
minutes or 
exercised on a 
cycle ergometer 
(~70% VO2 max) 
Men (n=11) & 
women (n=10), 
aged 21 ± 2 years, 
BMI 26 ± 4 (men)/ 
24 ± 2 (women) 
Regardless of sex 
acute exercise to 
suppress relative 
energy intake is 
effective 
Hazell et 
al. [69] 
N = 21, participated three sessions 
in a randomized crossover design: 
(1) MICT, 30-min cycling at 65% 
VO2Peak; (2) SIT, 6 × 30 s "all-out" 
sprints with 4-min recovery periods; 
(3) control (CTRL; no exercise); 
Determine whether 
any sex difference in total PYY, 
GLP-1 or perceived hunger exists 
following MICT/SIT 
Moderate-
intensity 
continuous 
exercise 
(MICT)/sprint 
interval exercise 
(SIT) 
Men & women 
(n=11), aged 
28.6±5.9 
(men)/30.5±7.9 
(women) years, 
BMI 23.7±2.2 
(men)/23.5±2.8 
(women) 
Total PYY/GLP-1 
respond differently to 
exercise in 
males/females over 
90 minutes following 
various exercise 
intensities 
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Table 2. (continued) 
Source Study Details Type of Exercise (Mode/Intensity) Study Population Key Findings 
 
Acute Exercise 
 
Shamlan et 
al. [70] 
N = 40, undertook either high-
intensity intermittent cycling 
(HIIC) consisting of 8 repeated 
60-second bouts of cycling at 
95% V̇O2 peak or low-intensity 
continuous cycling (LICC), 
equivalent to 50% V̇O2 peak, 
matched for energy cost (∼950 
kJ) followed by 90 minutes of 
rest; Randomized crossover 
design 
High-intensity 
intermittent cycling 
(HIIC)/low-intensity 
continuous cycling 
(LICC) 
Men & women 
(n=19), aged 18-35 
years, BMI 23.6 ± 
3.6, recruited from 
the University of 
Surrey and wider 
community 
High-intensity exercise, 
if energy matched, 
does not lead to 
greater appetite or 
energy intake, but may 
exert additional 
beneficial metabolic 
effects that may be 
more pronounced in 
males 
 
Chronic Exercise 
 
Hickey et 
al. [73] 
N = 18, determine the effect of 
aerobic exercise training on 
systemic leptin levels in 
humans,  
12-wk exercise training period; 
Randomized crossover design 
Aerobic exercise 
training (4 day/wk., 30-
45 min/day) 
Sedentary men & 
women (n=9), age 
48.8±1.8 
(men)/45.6±1.7 
years (women), 
BMI 32.1±1.1 
(men)/26.1±0.6 
(women)  
Women have higher 
circulating leptin 
concentrations despite 
lower fat mass and 
exercise training 
appears to have a 
greater effect on 
systemic leptin levels in 
females than in males 
Hagobian 
et al. [74] 
N = 18, sedentary men and 
women follow exercise training 
programs with ad libitum 
feeding, men lose body fat, but 
women do not; Purpose of this 
study was to evaluate whether 
this observation could be 
related to sex differences in the 
way energy-regulating 
hormones and appetite 
perception respond to exercise; 
Concentrations of hormones 
related to the regulation of 
energy intake/expenditure and 
perception of hunger/satiety 
were measured in three 
conditions: 1) after a no-
exercise day with subjects in 
energy balance, 2) after 4 days 
of daily exercise with energy 
added back to the baseline diet 
to match the higher expenditure 
and maintain energy balance 
(BAL), and 3) after 4 days of 
daily exercise without energy 
added to the baseline diet, so 
that subjects were in energy 
deficit (DEF); Counter-
balanced/cross-over study 
design 
Exercise bout was 
conducted on a 
treadmill (Life Fitness 
9100, Schiller Park, IL) 
at a moderate intensity 
(50–65% of estimated 
V̇O2 Peak) until 30% of 
total daily energy 
expenditure was 
expended 
Overweight/obese 
sedentary men & 
women (n=9), aged 
26.8±11.8 
(men)/23.3±8 
(women), BMI 
25.7±2.3 
(men)/28.0±3.5 
(women) 
In women-exercise 
altered energy-
regulating hormones in 
a direction expected to 
stimulate energy 
intake, regardless of 
energy status; In men-
the response to 
exercise was abolished 
when energy balance 
was maintained 
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2.3.3 Body Adiposity 
Even with the continuous rise of obesity today, observations of significantly 
varied whole-body adiposity are in individuals in westernized societies  [75]. The wide 
variability in whole-body adiposity levels is associated with numerous factors that 
modulate energy intake/expenditure [12]. Current evidence suggests that body adiposity 
can influence appetite-regulating hormone concentrations after exercise [26, 48, 76, 77]. 
Studies have indicated that fasting and post-prandial changes of certain appetite-
regulating hormones such as PYY, GLP-1, and acylated ghrelin are lowered and 
dampened as body fat increases [23, 78, 79]. Similarly, reports conclude that elevated 
leptin and insulin concentrations among overweight and obese populations studies [78, 
80]. However, continuous evaluation of leptin and insulin can result in these hormones' 
resistance and ineffectiveness [12]. Many exercise-induced weight control interventions 
that measure appetite-regulating hormone concentrations have been conducted at 
varying BMI levels, thus increasing individual variability in the changes in these 
hormonal concentrations [12]. Since BMI is unable to differentiate between fat mass 
from fat-free mass and can lead to inaccurate descriptions of lean, overweight, or obese, 
further studies should alleviate this discrepancy by defining body adiposity with specific 
body fat percentages [12]. 
Identified in Table 3, the purpose of this section is to discuss and consolidate 
recent findings of the modulating effects of body adiposity on concentrations of appetite-
regulating hormones with exercise-induced weight-loss interventions.  
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2.3.3.1 Acute Exercise 
Studies have reported that among lean, overweight, and obese populations, 
acylated ghrelin decreases and increases in PYY and GLP-1 during and after acute 
aerobic exercise in both populations [13, 21, 81, 82]. For instance, Larsen and 
colleagues found that after performing resistance exercise, total PYY and total GLP-1 
did not change in overweight males (Average BMI: 29.9 kg/m²), with similar findings in 
lean males (Average BMI: 23.7 kg/m²) [13, 21]. However, there are conflicting findings of 
the appetite-regulating hormone responses after different exercise intensities among 
lean, overweight, and obese subjects [12]. Two studies reported that neither moderate- 
nor high-intensity cycling altered circulating PYY concentrations in overweight/obese 
subjects, whereas a study conducted with lean subjects exhibited elevated PYY 
concentrations at greater exercise intensities [15, 17, 83, 84]. On the other hand, Unick 
et al. stated that overweight and obese females exhibited decreased GLP-1 
concentrations 1-hr after a single bout of moderate-intensity walking [85]. Recently, 
Holliday and Blannin demonstrated opposing results among overweight/obese subjects 
in which GLP-1 was elevated 1-hr after low-volume sprint interval cycling [81]. 
These findings' variance could be due to the heterogeneity in methods and 
outcome measurements among these studies. Others have mitigated this variability by 
direct comparison of subjects with directly comparing the same protocol [26, 86, 87]. For 
example, Ueda et al. observed that total PYY and GLP7-36 concentrations exhibited 
similar elevations up to 1-hr after moderate-intensity exercise in both lean (BMI: 19.1-
24.7 kg/m²) and overweight (BMI: 26.0-34.6 kg/m²) subjects [87]. Others have 
demonstrated overweight/obese subjects (BMI: 25.3-35.4 kg/m²) exhibit more 
outstanding total GLP-1 elevations after 60 minutes of moderate-intensity treadmill 
exercise (59% VO2 peak), while the lean (BMI: 19.6-24.5 kg/m²) group exhibited more 
significant elevations in exercise-induced total PYY concentration [26]. Regarding 
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acylated ghrelin, reports concluded the opposite, such as no modifications of acylated 
ghrelin concentrations in either overweight/obese or lean subjects after exercise were 
found [26]. Although studies that involve exercise intensities larger than 60% VO2 Peak, 
opposing results were found in which acylated ghrelin was suppressed [10, 11, 88, 89]. 
Even with inconsistent results among the given literature, the collective evidence 
suggests that lean and overweight/obese individuals exhibit similar acute exercise-
induced changes in energy intake [12]. When conducting future studies, inclusions 
should explain the inconsistencies in appetite-regulating hormones with varying body 
adiposity levels regarding body adiposities that influence appetite-regulating hormones. 
2.3.3.2 Chronic Exercise 
Most recent exercise for weight control studies that analyze body adiposity’s 
influence on appetite-regulating hormones are primarily conducted among 
overweight/obese populations and conclude that exercise training increases fasting 
hunger and postprandial satiety [15, 90]. Regarding the appetite-regulating hormones, 
decreases in leptin concentrations and increases in GLP-1 concentrations have been 
observed after four weeks of moderate-intensity cycling (55% VO2 Peak) in sedentary 
overweight males (Average BMI: 25.6 kg/m²) [24]. Similarly, Pil-Byung et al. observed 
decreases in leptin and total ghrelin concentrations after 8-weeks of combined 
resistance/aerobic training in sedentary individuals (BMI: 25.5 kg/m²) [91]. Both studies 
reported lower body weight and abdominal fat mass in response to exercise, which could 
mediate post-training changes in the appetite-regulating hormones [24, 91]. These 
findings suggest that individuals with more extensive pre-training adiposity exhibit more 
significant changes in appetite-regulating hormones, which are proportional to reductions 
in body fat post-intervention [24, 91]. A 12-week aerobic exercise intervention study 
conducted by Gibbons and colleagues supports these findings [92]. After the exercise 
intervention, in subjects who lost more weight, more massive elevated postprandial rises 
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in GLP-1 and total PYY concentrations, with more massive suppression in acylated 
ghrelin concentrations, were reported [15]. From a 12-weeks of high-intensity interval 
training intervention, similar findings such as increases in fasting acylated ghrelin were 
more significant in subjects that exhibited more extensive weight loss; however, this 
relationship in PYY3-36, or GLP-1 concentrations were not found [15]. With decreased 
bodyweight after aerobic exercise training, additional findings of acylated ghrelin, PYY3-
36, and GLP-1 reported no change in fasting or postprandial concentrations  [16, 33, 93]. 
Decreases in body fat also do not correspond to changes in acylated ghrelin and PYY 
concentrations after resistance exercise training in overweight and obese males [33].  
26 
Table 3. Overview of articles that analyzed the modulating effects of body adiposity on 
concentrations of appetite-regulating hormones with exercise. 
Source Study Details Type of Exercise (Mode/Intensity) Study Population Key Findings 
 
Acute Exercise 
 
Larsen et al. 
[13] 
N = 12; Completed four 
conditions in random 
order; Perceived 
appetite/appetite-related 
peptides/metabolites 
were assessed before/up 
to 2-hr post-condition 
(0P, 30P, 60P, 90P, 
120P); 
Randomized/counter-
balanced study design 
Completed four 
conditions in a 
random order: 1) 
non-exercise control 
(CON) (50 min 
seated rest); 2) AE 
(50 min cycling; 75% 
VO2Peak); 3) SE (10 
× 8 leg extensions; 
75% 1RM); and 4) 
CE (50% SE + 50% 
AE) 
Sedentary 
overweight males 
(n=12); aged 48 ± 5 
years; BMI: 29.9 ± 
1.9 
AE/SE/CE each have own 
distinct 
effects on circulating 
appetite-related 
peptides/metabolites; 
Despite differential 
exercise-induced 
hormone responses, 
exercise mode appears to 
have little effect on 
perceived appetite 
compared with a resting 
control in this population 
Balaguera-
Cortes et al. 
[21] 
N = 10; completed 3 
trials in a counter-
balanced design; study 
investigated the effect of 
an acute bout of 
resistance exercise, 
compared with aerobic 
exercise, on subsequent 
energy intake/appetite-
regulating hormone 
3 trials: (1)45 min of 
resistance exercise 
(RES; free and 
machine weights), 
(2) aerobic exercise 
(AER; running), (3) 
or a resting control 
trial (CON) 
Healthy active males 
(n=10); aged 21.3 ± 
1.4 years; BMI: 23.7 
± 2.0 
Differential response of 
appetite-regulating 
hormones to AER/RES 
does not appear to 
influence energy 
intake in the post-exercise 
meal 
Sim et al. 
[84] 
N =17; completed four 
30-min experimental 
conditions using a 
randomized counter-
balanced design; 
examine the acute 
effects of high-intensity 
intermittent exercise 
(HIIE) on energy intake, 
perceptions of 
appetite/appetite-related 
hormones in sedentary, 
overweight men 
Four Conditions: (1) 
CON: resting control, 
(2) MC: continuous 
moderate-intensity 
exercise (60% 
VO2Peak, (3) HI: 
high-intensity 
intermittent exercise 
(alternating 60 s at 
100% VO2Peak and 
240 s at 50% 
VO2Peak), (4) VHI: 
very-high-intensity 
intermittent exercise 
(alternating 15 s at 
170% VO2Peak and 
60 s at 32% VO2 
Peak) 
Sedentary 
overweight males 
(n=17), aged 30 ± 8 
years, BMI 27.7 ± 
1.6,  
High-intensity intermittent 
exercise suppresses 
subsequent ad-libitum 
energy intake in overweight 
inactive men 
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Table 3. (continued) 
Source Study Details Type of Exercise (Mode/Intensity) Study Population Key Findings 
 
Acute Exercise 
 
Martins et al. 
[17] 
N = 12; assigned to the 
control, MICC, HIIC, and 
S-HIIC conditions, 1-wk 
apart, in a counter-
balanced order; aim of 
the study was to 
compare the effects of 
acute isocaloric bouts 
(250 kcal) of high-
intensity intermittent 
cycling (HIIC)/moderate-
intensity continuous 
cycling (MICC)/short-
duration HIIC (S-HIIC) 
(125 kcal)/a resting 
control condition on the 
appetite hormone 
responses/subjective 
feelings of 
appetite/energy intake 
(EI)/food reward in 
overweight/obese 
individuals 
Four conditions: (1) 
high-intensity 
intermittent cycling 
(HIIC), (2) moderate-
intensity continuous 
cycling (MICC), (3) 
short-duration HIIC 
(S-HIIC), (4) and a 
resting control 
condition; Exercise 
was performed 1-hr 
after a standard 
breakfast 
Sedentary 
overweight/obese 
males & females 
(n=7), aged 33.4 ± 
10.0 years, BMI 32.3 
± 2.7  
In overweight/obese 
individuals, isocaloric bouts 
of moderate- or high-
intensity exercise lead to a 
similar appetite response 
Deighton et 
al. [83] 
N = 12; completed three 
8-hr trials (control), 
steady-state exercise 
(SSE), high-intensity 
intermittent exercise 
(HIIE)) separated by 1 
week; Counter-balanced 
Latin square design 
60 minutes of 3 
different exercise 
trials: (1) control, (2) 
steady-state 
exercise (SSE), (3) 
high-intensity 
intermittent exercise 
(HIIE) 
Healthy normal 
weight males (n=12), 
aged 22 ± 3 years, 
BMI 23.7 ± 3.0  
Acute bout of energy-
matched continuous 
exercise/HIIE were equally 
effective 
at inducing an energy 
deficit without stimulating 
compensatory increases in 
appetite 
Unick et al. 
[85] 
N = 19; underwent two 
experimental testing 
sessions in a counter-
balanced order: (1) 
exercise and (2) rest; 
study examined the 
acute effect of a bout of 
walking on hunger/ 
energy intake/appetite-
regulating hormones 
Two trials: (1) 
walking at a 
moderate intensity 
for approximately 40 
minutes (2) or rested 
for a similar duration 
Sedentary 
overweight/obese 
females (n=19), aged 
18-45 years, BMI 
25.0-39.9 
Hunger/energy intake were 
unaltered by a bout of 
walking suggesting that 
overweight/obese 
individuals do not acutely 
compensate for the energy 
cost of the exercise bout 
through increased caloric 
consumption 
Holliday & 
Blannin [81] 
N = 8; completed resting 
(REST)/exercise (EX) 
trials in a counter-
balanced order; Counter-
balanced/crossover study 
design 
Exercise consisted 
of 4 × 30 s “flat-out” 
cycling on an 
ergometer (adapted 
Wingate test) 
Active overweight 
males & females 
(n=4), aged 34 ± 12 
years, BMI 27.7 ± 1.7 
Little as 4 × 30 s of “flat-
out” cycling was sufficient 
to elicit a transient 
suppression of appetite/an 
enduring suppression of 
plasma acylated ghrelin; 
food intake 2-h post-
exercise was unaffected 
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Table 3. (continued) 
Source Study Details Type of Exercise (Mode/Intensity) Study Population Key Findings 
 
Acute Exercise 
 
Ueda et al. 
[87] 
N = 14; examined 
whether changes in gut 
hormone levels due to a 
single bout of aerobic 
exercise differ between 
obese young 
males/normal controls; 
attempted to determine 
the involvement of 
hormonal changes during 
exercise in the regulation 
of energy balance (EB); 
Randomized crossover 
design 
Two trials: (1) 
constant cycling 
exercise at 50% 
VO2Peak (2) or rest 
for 60 min 
Overweight/obese & 
normal weight males 
(n=7), middle-aged  
Findings suggest that 
short-term EB during a 
single exercise session 
might be regulated not by 
increased amounts of these 
gut hormones 
Douglas et 
al. [26] 
N = 47; study compared 
the acute effects of 
moderate-intensity 
exercise on 
appetite/energy 
intake/appetite-regulatory 
hormones in lean and 
overweight/obese 
individuals; completed 
two, 8-hr trials; 
Randomized crossover 
design 
Two trials: (1/2) 60 
minutes treadmill 
exercise (59% 
VO2Peak) at 0-1-hr 
and rested after 
healthy lean (n=22, 
11 females; aged 
37.5 (15.2) years; 
BMI 22.4 (1.5) and 
overweight/obese 
(n=25, 11 females; 
45.0 (12.4) years, 
BMI 29.2 (2.9) 
Acute moderate-intensity 
exercise transiently 
suppressed 
appetite/increased 
PYY/GLP-1 in the hours 
after exercise without 
stimulating compensatory 
changes in appetite in lean 
or overweight/obese 
individuals 
 
Chronic Exercise 
 
Morishima et 
al. [24] 
N = 22; conducted to 
determine change in 
regional fat accumulation 
and appetite-related 
hormonal response 
following hypoxic 
training; subjects 
underwent hypoxic (n = 
9, HYPO, FiO(2) = 15%) 
or normoxic training (n = 
11, NOR, FiO(2) = 
20·9%) during a 4-week 
period (3 days per week); 
Randomized crossover 
design 
4-week training at 
55% of maximal 
oxygen uptake 
(VO2Peak) for each 
condition 
Healthy sedentary 
males 33 ± 2 years; 
BMI 25.6 ± 0.8 
Hypoxic 
training for 4 weeks 
resulted in greater 
improvement in glucose 
tolerance without 
loss of whole-body fat 
mass, abdominal fat area 
or IMCL; Hypoxic training 
did not have synergistic 
effect on the regulation of 
appetite-related hormones 
Pil-Byung et 
al. [91] 
N =30; investigated the 
effects of an exercise 
program on appetite-
regulating hormones, 
inflammatory mediators, 
lipid profiles, and body 
composition; Randomly 
assigned to two groups 
(exercise group, EG, 
N.=15 and control group, 
CG, N.=15) 
- Healthy sedentary 
males  
Demonstrated the 
beneficial effects of an 
exercise program by 
altering appetite-regulating 
hormones, decreasing 
inflammatory factors, and 
improving lipid profiles and 
body composition in 
healthy young me 
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Table 3. (continued) 
Source Study Details Type of Exercise (Mode/Intensity) Study Population Key Findings 
 
Chronic Exercise 
 
     
Gibbons et 
al. [92] 
N = 32; examined the 
role of postprandial 
peptide response in 
compensatory eating 
during 12 weeks of 
aerobic exercise and in 
response to high-fat, low-
carbohydrate (HFLC) and 
low-fat, high-
carbohydrate (LFHC) 
meals; Randomized 
crossover design 
16 completed 12 
weeks of aerobic 
exercise and 16 non-
exercising control 
subjects were 
matched for age and 
body mass index 
Overweight/obese & 
normal weight males 
(n=16); age 18-55 
years, BMI 27-34 
No impact on postprandial 
peptide release was found 
after 12 weeks of aerobic 
exercise; Responders to 
exercise-induced weight 
loss showed greater 
suppression of acylated 
ghrelin and greater release 
of GLP-1 and total PYY at 
baseline 
Martins et al. 
[17] 
N = 46; Aim of this study 
was to determine the 
effect of 12-wk of 
isocaloric programs of 
moderate-intensity 
continuous training 
(MICT), high-intensity 
interval training (HIIT), or 
short-duration HIIT on 
subjective feelings of 
appetite, appetite-related 
hormones, and reward 
value of food; 
Randomized crossover 
design 
three training 
groups: (1) MICT (n 
= 14), (2) HIIT (n = 
16), (3) or short-
duration HIIT (n = 
16); three times per 
week 
Sedentary 
overweight/obese 
males & females 
(n=30), age of 34.4 ± 
8.8 years; BMI 33.3 ± 
2 
Study suggests that chronic 
HIIT has no independent 
effect on appetite or food 
reward when compared 
with an isocaloric program 
of MICT in obese 
individuals 
Guelfi et al. 
[33] 
N = 33; Investigate the 
effect of 12 weeks of 
aerobic (AER) compared 
with resistance training 
(RES) on perceived 
hunger and fullness, 
together with appetite-
related hormones in both 
the fasted state and 
postprandially; 
Randomized crossover 
design 
AER and RES 
completed 12 weeks 
of training (3 
sessions per week), 
while CON continued 
their sedentary 
routine 
Sedentary 
overweight/obese 
males; aged 49 ± 7 
years; BMI 30.8 ± 4.2 
Aerobic exercise training is 
associated with an increase 
in satiety, while an 
equivalent period of 
resistance training is not 
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2.3.4 Diet 
Diet is the pre-existing eating patterns/habits observed in an individual with 
varying macronutrient intakes [32]. Regarding macronutrients within a diet, the amount 
and combination of protein, carbohydrate, and fat can influence appetite-regulating 
hormone concentrations, thus influencing energy intake [94]. For instance, more 
significant increases of GLP-1 and PYY concentrations have been observed in males 
with high-protein intakes compared to both high-carbohydrate or high-fat intakes [54, 
95]. This suggests that a high-protein diet can increase sensations of satiety and 
potentially lead to greater weight loss by reducing energy intake. Tischmann et al. 
supported this relationship between protein and satiety by comparing diets with different 
macronutrient intakes in which a high-protein/moderate-carbohydrate diet demonstrated 
greater elevations in PYY than the moderate-protein/high-carbohydrate diet [94]. In 
contrast, others indicate that a high-carbohydrate/fat diet had greater increases in GLP-1 
than a high-protein diet [20]. These studies exhibit the influence of the diet’s 
macronutrient composition on appetite-regulating hormone mediation; however, further 
investigations are required to determine whether diet alterations in exercise training 
interventions can further promote or maintain significant weight loss. 
The studies that examine the influence of exercise-induced for weight loss 
interventions on diet and the effect they have on the concentrations of appetite-
regulating hormones are designated in Table 4. 
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2.3.4.1 Acute Exercise 
Recent literature suggests that different exercise types can alter diet; thus, 
altering appetite-regulating hormone concentration [14, 96]. Larson-Meyer observed 
increases in protein and fat intake and unchanged acylated ghrelin after 60 minutes of 
walking (70% VO2 peak), whereas after 60 minutes of running (70% VO2 peak), 
macronutrient intake was unchanged and acylated ghrelin was increased [14]. Similarly, 
Finlayson et al. demonstrated that after 50 minutes of vigorous-intensity cycling (70% 
VO2 peak), subjects had a greater preference for energy-dense foods [96]. Conversely, 
Jokisch and colleagues found that meal macronutrient intake did not differ after exercise 
≥150 min/week or ≤60 min/week, whereas Charlot and Chapelot exhibited after 60 
minutes of exercise, fat and protein intake was increased [97, 98]. 
2.3.4.2 Chronic Exercise 
An exercise training intervention and its effect on energy and macronutrient 
intakes and the appetite-regulating hormones are difficult to explain since most exercise 
training studies recruit sedentary subjects at baseline [12]. Nevertheless, measured 
fasting- and postprandial appetite and energy intake in subjects is typically observed in 
cross-sectional studies [99, 100]. Van Walleghen and colleagues demonstrated that 
exercise training subjects had greater energy and protein intake than the sedentary 
subjects [100]. Regarding studies investigating the effect of exercise training 
interventions on appetite-regulating hormones, the amount of literature is low [12]. 
However, one study found that fasting acylated ghrelin and GLP-1 concentrations were 
elevated in the exercise training group compared to the sedentary group, whereas total 
PYY was not significantly different between both groups [99]. This indicates that 
increased exercise training duration can increase energy compensation through 
manipulating appetite-regulating hormone mediation, thus reducing the 
promotion/maintenance of weight loss.  
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Table 4. Overview of articles that analyzed the modulating effects of diet on 
concentrations of appetite-regulating hormones with exercise. 
Source Study Details Type of Exercise (Mode/Intensity) Study Population Key Findings 
 
Acute Exercise 
 
Larson-
Meyer et al. 
[14] 
N = 19, Plasma 
concentrations of the 
orexigenic peptide 
ghrelin/anorexigenic 
peptides PYY/GLP-
1/appetite ratings were 
measured at 30 min interval 
for 120 min, followed by a 
free-choice meal 
Counter-balanced cross-over 
study design 
Purpose of this study was to 
assess the effect of a 60-
minute bout of exercise on 
circulating concentrations 
ghrelin/PYY/GLP-1; 
appetite/ad libitum food 
intake among women 
60 minutes of 
running/60 minutes of 
walking 
Healthy active 
women (runners = 
9), aged 18-40 
years, BMI 19.8-
22.1 
Exercise-induced 
alterations in appetite 
are likely driven by 
complex changes in 
appetite-regulating 
hormones rather than 
change in a single gut 
peptide 
Finlayson et 
al. [96] 
N = 24, designed to examine 
hedonic/homeostatic 
mechanisms involved in the 
acute effects of exercise on 
food intake, conformed to a 
within-subjects design 
consisting of two 
counterbalanced conditions 
separated by approximately 
one week 
Two conditions were 
(1) moderate-intensity 
exercise (Ex) which 
involved stationary 
cycling at 
approximately 70% 
maximum heart rate for 
50 min, and (2) 50 min 
of no exercise (NEx) 
Healthy females, 
aged 18-40 years, 
BMI 20-25, 
staff/student 
population of the 
University of 
Leeds 
Exercise-induced 
changes in the hedonic 
response to food could 
be an important 
consideration in the 
efficacy of using 
exercise to lose weight; 
An enhanced implicit 
wanting for food after 
exercise may help to 
explain why some 
people 
overcompensate 
during acute eating 
episodes; Individuals 
could be resistant to 
the beneficial effects of 
exercise due to a 
predisposition to 
compensate for 
exercise-induced 
energy expenditure as 
a result of implicit 
changes in food 
preferences 
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Table 4. (continued) 
Source Study Details Type of Exercise (Mode/Intensity) Study Population Key Findings 
 
Acute Exercise 
 
Charlot & 
Chapelot [98] 
N = 18, assessed role of 
‘fatness/fitness’ in inter-
individual variability, within-
subject design/subjects 
separated into two groups 
according to their body 
fatness/fitness 
status/completing in random 
order the two following test 
conditions: (1) 60 min of 
exercise (EX)/(2) 60 min of 
rest (RT) 
After 5 min warm-up 
period at 75 W, the 
workload was 
progressively 
increased over a 10 
min period until the 
subjects reached 70 % 
of their VO2Peak, 
intensity was then 
maintained over 45 
min, continuous gas 
exchange permitted 
measurement of 
EE/constant 
adjustment of the 
workload so that 
exercise was 
maintained at the 
desired intensity 
Non-obese males, 
aged 18-25 years, 
recruited through 
board 
advertisements in 
the Paris 13 
University area 
(Paris, France) 
Energy cost of an 
aerobic exercise 
session was partially 
compensated over the 
next 24-hr 
independently of the 
fatness/fitness status, 
but high-fat/low-fit 
individuals 
compensated more 
specifically on fats 
 
Chronic Exercise 
 
Van 
Walleghen et 
al. [100] 
N = 54, On two occasions, 
young active (n = 15), young 
sedentary (n = 14), older 
active (n = 14) and older 
sedentary (n = 11) subjects 
consumed either a high-
energy yogurt preload 
beverage (YP: 500 ml, 1988 
kJ, men; 375 ml, 1507 kJ, 
women), or no preload (NP), 
30 min before an ad libitum 
test meal,  
Not permitted to 
exercise 
Healthy non-obese 
young physically 
active (aged 21–
35 years) and 
sedentary/older 
physically active 
(aged 60–80 
years) and 
sedentary adults  
Acute EI regulation is 
impaired in older 
adults, which is not 
attenuated by physical 
activity status; EI 
regulation over the 
course of a day is more 
accurate in active vs 
sedentary adults, 
which may facilitate 
long-term energy 
balance 
Lund et al. 
[99] 
N = 20, aim of this study was 
to assess and compare gut 
hormone response and 
satiety changes after a liquid 
meal intake in young, healthy 
trained (T)/ untrained (UT) 
males 
Cross sectional in design 
and a prospective 
intervention study 
T group was regular 
aerobic exercise 
performers doing long 
distance 
running/bicycling or 
triathlon ([three 
exercise bouts a week) 
during several years 
with a VO2Peak [60 ml 
- min-1 kg-1 body 
weight 
UT group with a 
sedentary lifestyle, did 
not perform any 
aerobic/resistance 
exercise, during at 
least the last 6 months 
and a VO2Peak\50 ml 
min-1 kg-1 body weight 
Health normal 
weight males 
(n=20), aged 25±1 
year, BMI ~22±1, 
recruited through 
notices posted on 
the Copenhagen 
University bulletin 
boards/in student 
magazines 
Satiety measures did 
not differ between 
groups throughout the 
test; Possible that in 
aerobically T subjects, 
lower GIP release is 
partly responsible for a 
lower postprandial 
incretin stimulated 
insulin secretion 
  
34 
2.3.5 Types of Exercise Training 
Several exercise-induced weight loss intervention studies support the 
correlations between exercise training with appetite-regulating hormone regulation [10, 
12, 13, 16, 21, 25, 27, 28]. However, these studies' methodology and outcome 
measurements are widely diverse, making it difficult to determine the most efficient type 
of exercise that should be applied to increase the promotion/maintenance of weight loss 
[12]. The type of exercise in exercise training interventions are shaped by two factors: 
mode and frequency [12, 13]. The exercise mode is typically described as either aerobic 
or anaerobic, whereas exercise frequency is defined as the number of times the exercise 
is performed per week [16]. Various findings indicate whether aerobic/anaerobic 
exercise or a specific exercise frequency will differentially influence changes in appetite-
regulating hormone concentrations [12, 16]. Recent studies that monitor these 
differentiating types of exercise will be further investigated to help understand the 
discrepancies in the literature [10, 12, 16]. 
The purpose of this section is to evaluate recent studies that observe the effect of 
exercise mode and frequency on the appetite-regulating hormones designate in Table 5. 
2.3.5.1 Mode 
It is suggested that exercise mode has no differing effects on energy intake. 
However, aerobic and anaerobic exercise have been demonstrated to have distinct and 
specific appetite-regulating responses [10, 13]. Larsen et al. found differing exercise-
induced hormone responses in different exercise modes exhibited minimal effects on 
perceived appetite [13]. However, further investigation is considered due to the absence 
of total energy expenditure measurements and short study durations [13]. Cadieux et al. 
conducted a study that evaluated these parameters and found similar findings in which 
varying exercise modes exhibited no differences in energy intake [25].  
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2.3.5.2 Frequency 
Dorling et al. elaborate on how the number of days per week an individual 
performs exercise could play a vital role in manipulating the appetite-regulating 
hormones [12]. Guelfi et al. found negligible differences after a short or long duration of 
exercise [33]. Recent literature on the effect of exercise frequency on the appetite-
regulating hormones is scarce [12]. Two studies found that after a short and long 
duration of exercise training, the hormone concentrations of PYY, GLP-1, and PYY 
increased; however, there was no significant difference in the amount these hormones 
increased in either durations [13, 15]. Due to the limited amount of literature, the effect of 
the frequency of exercise on the appetite-regulating hormones is another parameter that 
should be further investigated [12].  
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Table 5. Overview of articles that analyzed the modulating effects of exercise mode and 
frequency on concentrations of appetite-regulating hormones. 
Source Study Details Methods Compared Study Population Key Findings 
 
Mode 
 
Larsen et al. [13] N = 12; Completed four 
conditions in random 
order; Perceived 
appetite/appetite-related 
peptides/metabolites were 
assessed before/up to 2-hr 
post-condition (0P, 30P, 
60P, 90P, 120P); 
Randomized/counter-
balanced study design 
Completed four 
conditions in a 
random order: 1) 
non-exercise 
control (CON) (50 
min seated rest); 
2) AE (50 min 
cycling; 75% 
VO2Peak); 3) SE 
(10 × 8 leg 
extensions; 75% 
1RM); and 4) CE 
(50% SE + 50% 
AE) 
Sedentary overweight 
males (n=12); aged 48 
± 5 years; BMI: 29.9 ± 
1.9 
AE/SE/CE each have 
own distinct 
Broom et al. [10] N = 11; Completed three 
exercise trials with 
different conditions; 
Ratings of hunger and 
plasma concentrations of 
acylated ghrelin and PYY 
were measured and 
compared throughout the 
study; Purpose was to find 
the effects that resistance 
exercise has on appetite; 
Randomized crossover 
design 
Three, 8-hr trials: 
1) Resistance 
exercise: 90-min 
free weightlifting 
session followed 
by 6.5-hr rest 
period; 2) Aerobic 
exercise: 60-min 
run followed by 7-
hr rest period; 3) 
Control: 8-hr rest 
Healthy male students 
(n=11); aged 21.1 ± 
0.3 years; BMI: 23.1 ± 
0.4; maximum oxygen 
uptake: 62.1 ± 1.8 
ml∙kg-1∙min-1 
PYY concentrations 
were greater with the 
aerobic exercise trial 
than the other trials; 
Could indicate ghrelin 
and PYY may 
regulate appetite 
during and after 
exercise 
Cadieux et al. 
[25] 
N = 16; Objective was to 
evaluate the effects of 
exercise modality on 
energy intake (EI), total 
energy expenditure (TEE), 
non-exercise activity 
thermogenesis (NEAT), 
and post-exercise energy 
compensation (PEEC) 
measured acutely, as well 
as for 10-hr and 34-hr 
following exercise; 
Randomized crossover 
design 
Three randomized 
crossover 
sessions: 1) 
Resistance 
(Training protocol; 
70% VO2Peak): 
Performed until the 
energy cost of 
exercise (ExEE) 
was reached; 2) 
Aerobic (Treadmill; 
70% VO2Peak): 
Performed until the 
target ExEE was 
reached; 3) 
Control: Had to 
remain seated 
during the 1-hr 
session and were 
only allowed to 
read 
Healthy sedentary 
males (n=8) and 
females (n=8); aged 
21.9 ± 2.6 years; BMI: 
22.8 ± 1.8; maximum 
oxygen uptake 
(VO2Peak): 53.0 ± 8.6 
ml∙kg-1∙min-1 
No differences in EI 
between modes of 
exercise, as well as 
10-hr and 34-hr 
following exercise; 
Modality by sex 
interaction was found 
for acute EI (men ate 
more after the 
resistance session 
than the aerobic 
session, while women 
showed no 
difference); No 
differences found 10-
hr and 34-hr post-
exercise in TEE, 
NEAT and PEEC; 
Positive correlation  
found between both 
modalities across 
subjects for PEEC ( r 
= 0.897; P < 0.01) 
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Table 5. (continued) 
Source Study Details Methods Compared Study Population Key Findings 
 
Frequency 
 
Guelfi et al. [33] N = 33; Investigate the 
effect of 12 weeks of 
aerobic (AER) compared 
with resistance training 
(RES) on perceived 
hunger and fullness, 
together with appetite-
related hormones in both 
the fasted state and 
postprandially; 
Randomized crossover 
design 
AER and RES 
completed 12 
weeks of training 
(3 sessions per 
week), while CON 
continued their 
sedentary routine 
Sedentary 
overweight/obese 
males; aged 49 ± 7 
years; BMI 30.8 ± 4.2 
Aerobic exercise 
training is associated 
with an increase in 
satiety, while an 
equivalent period of 
resistance training is 
not 
Larsen et al. [13] N = 12; Completed four 
conditions in random 
order; Perceived 
appetite/appetite-related 
peptides/metabolites were 
assessed before/up to 2-hr 
post-condition (0P, 30P, 
60P, 90P, 120P); 
Randomized/counter-
balanced study design 
Completed four 
conditions in a 
random order: 1) 
non-exercise 
control (CON) (50 
min seated rest); 
2) AE (50 min 
cycling; 75% 
VO2Peak); 3) SE 
(10 × 8 leg 
extensions; 75% 
1RM); and 4) CE 
(50% SE + 50% 
AE) 
Sedentary overweight 
males (n=12); aged 48 
± 5 years; BMI: 29.9 ± 
1.9 
AE/SE/CE each have 
own distinct 
Martins et al. [17] N = 46; Aim of this study 
was to determine the 
effect of 12-wk of 
isocaloric programs of 
moderate-intensity 
continuous training 
(MICT), high-intensity 
interval training (HIIT), or 
short-duration HIIT on 
subjective feelings of 
appetite, appetite-related 
hormones, and reward 
value of food; Randomized 
crossover design 
three training 
groups: (1) MICT 
(n = 14), (2) HIIT (n 
= 16), (3) or short-
duration HIIT (n = 
16); three times 
per week 
Sedentary 
overweight/obese 
males & females 
(n=30), age of 34.4 ± 
8.8 years; BMI 33.3 ± 
2 
Suggested that 
chronic HIIT has no 
independent effect on 
appetite or food 
reward when 
compared with an 
isocaloric program of 
MICT in obese 
individuals 
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2.4 Conclusion 
Understanding the effect of sex, body adiposity, diet, and exercise type 
differences on appetite-regulating hormones with exercise training provides aid in the 
future direction literature should take. In recent literature, it is difficult to distinguish all 
the potential factors that modulate the appetite-regulating hormones in exercise training 
interventions due to the heterogeneity in methodologies and outcome measurements 
[12]. Although it appears that sex, body adiposity, and diet can influence concentrations 
of the appetite-regulating hormones to some degree, whereas exercise mode and 
frequency do not have different effects on these hormones. Further investigation into 
these factors is crucial for the development of future exercise training for weight control 
interventions. This information can be used by health care professionals to provide the 
most accurate exercise training recommendations that give the best results among 
overweight and obese populations. 
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CHAPTER 3. Materials and Methods 
3.1 Research Design 
The study was a randomized, controlled trial that included a 12-week exercise 
intervention with exercise frequencies of either six sessions (days) per week, two 
sessions per week, or a sedentary control group (no exercise), blocked by sex. 
Concentrations of ghrelin, leptin, glucagon-like peptide 1 (GLP-1), and insulin were 
assessed before (fasting, minute 0) and after a standardized meal at minute 15, 30, 45, 
60, 90, 120, 150, and 180 at baseline and after the 12-week exercise intervention (post). 
Regarding exercise treatments, subjects were directed to only aerobic exercise (walking, 
running, biking, treadmill, elliptical, or stationary bike). A Polar A-300 heart rate monitor 
(watch and chest-/waist-strap) had to be worn during exercise, with subjects reporting 
back to the lab weekly to download and record each exercise session. Weekly meetings 
allowed to monitor adherence to the prescribed amount of exercise (2- or 6-days per 
week) and evaluate exercise-induced energy expenditure. 
3.1.1 Recruitment 
Recruitment occurred in and around Lexington, Kentucky, beginning in the winter 
of 2018 and ending in the spring of 2019. The inclusion criteria included BMI between 25 
to 35 kg/m2, 18 to 40 years of age, no physical limitations or major health problems, and 
not pregnant or planning a pregnancy in the next six months. The exclusion criteria 
included dieting over the past three months, tobacco use, taking metabolic altering 
medications, regularly exercising in the last six months, and any medical condition 
preventing safe exercise. The subjects collected had a BMI ranging from 25 to 35 kg/m2, 
were weight-stable (not lost or gained 5% of their current body weight in the last six 
months), sedentary (not engaging in exercise), free of any metabolic or cardiovascular 
disease, not pregnant or nursing, and not participating in a weight loss diet or taking any 
appetite-regulating medications. 
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3.1.2 Subjects 
A total of 53 participants volunteered and were randomized into one of three 
groups. Of these, 44 participants completed the study (32 women), with six (four women) 
withdrawing for personal reasons, and two female participants were excluded for 
noncompliance. Six individuals (3 females) did not have valid data for the hormonal 
mediators of hunger (processing or equipment error). Thus, 37 subjects (29 females) 
completed the 12-week intervention and were included in the analyses. All subjects had 
a body mass index (BMI) ranging from 25-35 kg/m2, were weight-stable (not lost or 
gained 5% of their current body weight in the last six months), sedentary (not engaging 
in exercise), free of any metabolic or cardiovascular disease, not pregnant or nursing, 
and not participating in a weight loss diet or taking any appetite-regulating medications. 
The study was approved by the University of Kentucky Institutional Review Board and is 
registered with Clinicaltrials.gov identifier: NCT03413826. 
3.1.3 Procedures 
Subjects provided their written informed consent and were screened of eligibility 
criteria at an initial screening and consent visit. Screening of eligibility criteria included 
completing a health history and physical activity readiness questionnaire (PARQ), the 
Preference for and Tolerance of the Intensity of Exercise Questionnaire (PRETIE-Q), 
and an online survey of their weight loss history. Physical activity was objectively 
assessed for seven days before completing the baseline testing by an ActiGraph 
accelerometer that was provided and worn by each participant. During subsequent visits 
before and after the exercise intervention, the energy expenditure rate, resting energy 
expenditure (REE), body composition, and hormonal response to a standardized 
breakfast meal were obtained. 
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3.1.4 Exercise Intervention 
A Polar A-300 heart rate monitor (watch and chest-/waist-strap) was provided to 
each subject to be worn during each exercise session of the 12-week intervention. The 
intervention was based on a previous study that demonstrated a compensatory 
response of roughly 1,000 kcal/day regardless of kcal expended per week (either 3,000 
or 1,500 kcal) [101].  In the present investigation, subjects were instructed to exercise 
either 2- or 6-days per week (exercise group) or remain sedentary (control group). 
Subjects in the 2-day per week group were instructed to complete at least two exercise 
sessions per week (90 to 120 minutes per session), whereas the 6-day per week group 
was to complete at least six exercise sessions per week (40 to 60 minutes per session). 
Those in the exercise group were instructed to report back to the lab weekly to meet with 
the research staff where exercise sessions recorded on the Polar A-300 were 
downloaded using the PolarFlowTM software. During each download meeting session, 
research staff provided feedback to subjects on their amount of time and energy 
expended from each session's prior week. These meetings also allowed the research 
staff to evaluate the exercise sessions and track compliance with the intervention. 
Compliance was defined as completing at least 90% of the instructed exercise sessions 
per month. Subjects that did not complete at least 90% of expected exercise sessions 
per month were dropped from the study. The exercise session reports that were 
downloaded provided the amount of time the subject spent in each heart rate zone, 
which was used to calculate the energy expended during exercise (exercise energy 
expenditure, ExEE). The intensity was self-selected as long as subjects were in at least 
in HRR zone 1. Dietary habits were instructed not to be changed during the 12-week 
intervention. 
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3.2 Assessments 
3.2.1 Physical Activity 
At baseline, habitual, free-living physical activity was measured by an ActiGraph 
accelerometer (GT3X+ model; Pensacola, Florida) to ensure subjects were sedentary, 
i.e., not engaging in structured exercise, before baseline testing. Subjects wore the 
monitor at the waistline during all awake hours, apart from bathing and swimming. The 
monitor's data was recorded weekly to determine minutes of vigorous physical activity 
(VPA) with consecutive strings of zeros greater than 20 minutes or non-wear time, 
removed from recordings. Data of VPA was determined by using the Crouter et al. 
algorithm, and Freedson cut points. VPA was used to determine exercise behaviors 
instead of the more typical moderate to vigorous physical activity (MVPA), as non-
exercise behaviors such as walking would be included in MVPA but not necessarily 
indicative of purposeful exercise. This was the case with many subjects who were part of 
a large University system and required to walk across a sprawling campus daily.   
3.2.2 Rate of Energy Expenditure 
The rate of energy expenditure at five different heart rate zones was calculated 
using a graded exercise treadmill test using the Trackmaster TMX428 Metabolic cart 
interface treadmill with integrated 12-lead ECG. Indirect calorimetry was used to analyze 
oxygen (O2) consumption, and carbon dioxide (CO2) expired. The initial start of the test 
included a five-minute warm-up walk at 0% grade and 3.0 mph. After completion, the 
treadmill grade was increased to 2.5% for three minutes and every three minutes after 
that until an approximate 10-beat peat per minute increase in heart rate was produced 
from the previous stage with speed unchanged at 3.0 mph. Subjects continued the test 
until a heart rate of 85% heart rate reserve (HRR) was achieved or if they could not 
continue. The rate of energy expenditure (kcal per minute) was determined by the Weir 
equation [102] for each heart rate zone. Precisely, the rate of energy expenditure (kcal 
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per minute) at different heart rate zones was calculated by regressing the average rate 
of energy expenditure during the last 30-seconds of each stage against the average 
heart rate from the last 30-seconds of the corresponding stage. Subjects completed the 
following test at baseline and at six-weeks to formulate a new regression equation and 
thus new values for the rate of energy expenditure for each stage to account for 
improvements in fitness when starting an exercise intervention. Using the average rate 
of energy expenditure at each heart rate zone and the time spent exercising in each 
zone (provided from Polar Heart Rate Monitor), the training-induced exercise energy 
expenditure (TrEE) of each session was calculated, which was used to determine total 
exercise energy expenditure (ExEE) and compensation index (CI). 
3.2.3 Resting Energy Expenditure 
REE was measured at baseline and post as this value was needed to calculate 
ExEE and alterations in metabolic activity. Indirect calorimetry (Quark RMR; Cosmed 
USA, Chicago, IL) with a ventilated canopy was used to measure REE. Participants 
were instructed to arrive fasted (~10-hr) and remain awake for the 45-minute test. REE 
was measured for 30-minutes after a 15-minute rest in the supine position. The 
additional 15-minutes were required to develop the steady-state, defined as <10% 
fluctuation in O2 consumption and <5% fluctuation in the respiratory quotient (RQ), which 
is needed for a valid REE.O2 consumed, and CO2 produced determined 24-hour REE 
(kcal) using the Weir equation [102]. 
3.2.4 Body Composition 
A GE Lunar iDXA machine measured body composition for each participant at 
baseline and post. The GE Lunar iDXA machine, performed using thick mode 
recommended by the software, provided a total body scan to obtain the absolute and 
relative measurements of total body and regional soft tissue masses such as fat mass 
(FM), fat-free mass (FFM), and mineral-free lean (MFL). iDXA scans were analyzed 
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using GE Lunar enCORE Software (13.60.033) with calibration performed before each 
session. From this assessment, FM and FFM measurements were obtained and used to 
calculate accumulated energy balance (AEB) since alterations in energy balance have 
been observed to correspond with changes in body composition [103]. 
3.2.5 Appetite-Regulating Hormones 
The appetite-regulating hormone’s concentrations were obtained by standard 
blood collection procedures at the outpatient wing of the University of Kentucky’s CCTS 
hospital after a 10 to 14-hr overnight fast. Concentrations of ghrelin, leptin, GLP-1, and 
insulin were assessed before (fasting, minute 0) and after consumption of a 
standardized breakfast meal, that was 20% of the subjects’ estimated energy needs. 
Selection of these specific hormones based on the most common hormones implicated 
in exercise-induced increases in appetite [13]. The estimated energy needs were found 
based on the subject’s REE and the sedentary activity factor of 1.4. The standardized 
breakfast meal consisted of one Nutra-grainTM bar and cornflakes with 2% milk (an 
unsweetened soymilk substitute was optional for lactose-intolerant participants). The 
completion of the meal consumption was instructed to be within 15 minutes; after 
consumption, the first blood draw initiation was initiated. The blood draws were 
completed in 15-minute increments 15, 30, 45, 60 for the first hour and 30-minute 
increments (90, 120, 150, 180) during the second hour. EDTA-coated and serum tubes 
were used to collect the blood samples. Serum insulin was measured with a 
chemiluminescent immunometric assay (Siemens), whereas ghrelin, leptin, and GLP-1 
were measured using enzyme-linked immunosorbent assay (ELISA, Millipore, Phoenix 
Pharmaceuticals, Alpco). 
3.2.6 Energy Compensation 
To calculate compensation for energy expended during exercise, AEB was 
calculated from FM and FFM changes and converted to kcal equivalents. Gaining 1kg 
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FM and 1kg FFM reflected as 12,000 kcal and 1,780 kcal, respectively, whereas losing 
1kg FM and 1kg FFM reflected as -9,417 kcal and -884 kcal, respectively [104, 105]. 
After calculating AEB, ExEE was calculated from training-induced energy expenditure 
(TrEE) with an addition of 15% excess post-exercise energy expenditure acquired after 
exercise sessions (TrEE * 0.15), and subtracting the basal energy expenditure (REE * 
1.2) that would have occurred during the exercise session so not to include it twice [106]. 
The final equation to calculate ExEE is as follows: ExEE = (TrEE * 0.15) + (TrEE – 
training duration * (REE * 1.2)). CI was calculated to assess the percentage of ExEE 
compensated for. The total amount of kcal compensated was calculated first by adding 
AEB (a negative value if participants decreased body weight) to ExEE. In the following 
equation, (ExEE + AEB)/ExEE x 100%, the number of total kcal compensated was 
converted to form a percentage, referred to as percent kcal compensated, or CI. Thus, a 
positive CI depicts a negative energy balance less than ExEE (participants at least 
partially compensated for the energy they expended during exercise). A negative value 
indicates that energy balance is more negative than expected, or the participants lost 
more weight than energy expended. When CI equals zero, subjects lost the same weight 
as the energy they expended, i.e., they did not compensate. 
3.3 Statistical Analysis 
T-tests were performed to determine baseline group differences in sex, age, BMI, 
VPA, REE/kg FFM, RQ, VO2 peak, and exercise training-induced variables (ExEE, AEB, 
and CI) at post-testing. The primary outcomes were CI, kcal compensated, percent body 
fat loss, and appetite-regulating hormone concentrations with interest in how these 
variables related to exercise dose defined as sessions per week, ExEE per week, time 
spent exercising per week, and exercise intensity (percent time spent exercising in HRR 
zones 3-5). Linear mixed-effects models were used to model the relationships between 
time point (12 weeks vs. baseline) and group over time (minutes 0 to 180) for the 
46 
concentrations of appetite-regulating hormones (leptin, ghrelin, GLP-1, and insulin). 
Post-prandial changes in appetite-regulating hormone concentrations were evaluated as 
changes in the area under the curve (delta-AUC), calculated by the trapezoidal rule. 
Over time group differences, between-group differences, and group-time interactions in 
primary outcomes were tested by repeated-measures two-way ANOVA, with sex and 
age included as covariates.  
Additionally, ANCOVA analyses were performed for the delta-AUC of appetite-
regulating hormones and body weight/FM; both bodyweight and FM were presented as 
percent change and raw values. Bivariate correlation analysis was used to calculate 
correlates of CI and percent body fat loss. Linear regression analyses were used to 
predict CI and percent body fat loss using leptin delta-AUC, ghrelin delta-AUC, exercise 
group (exercise frequency), time spent exercising per week, ExEE per week, and 
exercise intensity as independent variables. All analyses were performed in IBM SPSS 
Version 26 (IBM Corporation, Armonk, NY).  
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CHAPTER 4. Results 
In Table 6, no differences in baseline characteristics (sex, age, BMI, VPA, REE/kg 
FFM, RQ, VO2 peak) between groups. Exercise training-induced variables and 
differences in weekly ExEE, time spent exercising, and percent body fat loss are found 
in Table 7. All participants engaged in less than 90 minutes of VPA per week with an 
average of 47.73 ± 6.13 in the 6-day per week group and an average of 52.31 ± 4.62 in 
the 2-day per week group. As expected, the 6-day group expended more energy and 
exercised longer per week than the 2-day (P<0.05). CI did not differ between groups 
(P>0.05); as such, only the 6-day group lost FM, P=0.03. The control group % body fat 
loss change was different from both exercise groups, P<0.05. Results from the mixed-
effects models indicated only ghrelin (P=0.03) and leptin (P<0.01) had significant group 
by time interactions, decreasing to a greater extent in 6d than 2d or control. 
Changes over time and between groups for delta-AUC of the appetite-regulating 
hormones are presented in Table 8. Between-group changes for Leptin-delta-AUC in 
both the 6-day and 2-day groups were different from the control group. Changes over 
time (baseline to post) in leptin-delta-AUC were only different in the 6-day per week 
group (P<0.05). No other hormones (delta-AUC) demonstrated significant changes over 
time or between groups.  
Listed in Tables 9 and 10 are the results from the linear regression analyses 
predicting CI and percent body fat change. Leptin-delta-AUC was the only independent 
predictor of CI while controlling for percent body fat loss change and ExEE. Ghrelin-
delta-AUC was the only independent predictor of percent body fat loss change when 
controlling for CI and ExEE.  
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Table 6. Baseline differences in demographics (sex, age, BMI) vigorous physical 
activity, and metabolic rates (REE/Kg FFM) of participants between groups (includes 
all randomized participants). 
 
6-day per week group 
N=19 
2-day per week group 
N=20 
Control 
N=14 
Sex (% female) 68.40 85.00 78.80 
Age (years) 29.32 ± 7.27 28.56 ± 5.85 26.00 ± 7.80 
BMI1 29.00 ± 2.87 30.51 ± 3.47 29.36 ± 2.87 
VPA2 9.08 ± 12.88 8.57 ± 17.45 12.91 ± 19.87 
REE/Kg FFM3 31.52 ± 4.76 33.86 ± 4.75 33.37 ± 4.62 
RQ4 0.93 ± 0.10 0.90 ± 0.09 0.92 ± 0.06 
VO2 Peak5 39.76 ± 4.56 38.45 ± 2.57 39.95 ± 4.84 
Data as mean ± SD. 
1BMI: Body Mass Index, kg/m2. 
2VPA: Minutes of VPA assessed objectively assessed via accelerometry using Freedson cut points. 
3REE/Kg FFM: Resting energy expenditure per kg FFM, in kcal per 24-hr, assessed from indirect 
calorimetry. Calculated via the Weir equation from O2 consumed and CO2 produced. 
4RQ: Respiratory quotient, CO2 produced divided by O2 consumed during resting energy expenditure test. 
5VO2 Peak: Estimated from submaximal exercise test, mL∙kg-1∙min-1. 
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Table 7. Resulting data from the exercise intervention between groups that exercised. 
 6-day per week group N=15 
2-day per week 
group 
N=17 
All participants 
N=32 
Exercise Time/week1, * 320.50 ± 20.40 188.80 ± 12.00 249.41 ± 16.85 
% Time in Zone 3-52 47.73 ± 6.13 52.31 ± 4.62 50.32 ± 3.69 
% Time in Zone 1-23 52.11 ± 5.68 47.69 ± 4.62 49.67 ± 3.69 
ExEE/week4, * 2,753.50 ± 144.90 1,490.70 ± 122.10 2,041.68 ± 150.80 
Kcal compensated/week5 1,309.86 ± 274.50 715.42 ± 268.60 961.39 ± 198.70 
Total exercise time6 3,944.20 ± 242.80 2,265.40 ± 143.40 2,992.90 ± 202.20 
Total ExEE7 33,091.00 ± 2,112.80 17,562.00 ± 1,547.70 24,291.00 ± 1,895.00 
Total kcal compensated8 15,718.00 ± 3,294.1 8,585.00 ± 3,223.00 11,537.00 ± 2,384.20 
AEB9 −16,789.00 ± 3,589.80 −8,977.30 ± 3,515.30 −12,363.00 ± 2,586.70 
CI10 55.43 ± 10.16 49.31 ± 20.56 50.25 ± 12.27 
Kg weight loss11 −1.04 ± 0.45^ −0.76 ± 0.60 −0.59 ± 0.38 
% weight loss12 −1.48 ± 0.64^ −0.84 ± 0.66 −1.09 ± 0.45 
Kg body fat loss13, * −1.82 ± 0.39^ −0.64 ± 0.44 −0.58 ± 0.34 
% Body fat loss14, * −7.70 ± 2.04^* −1.86 ± 1.27# −4.43 ± 1.30 
Delta REE/kg FFM15 1.06 ± 0.94 −1.45 ± 1.08 −0.38 ± 0.81 
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Table 7. (continued) 
 6-day per week group N=15 
2-day per week 
group 
N=17 
All participants 
N=32 
Delta RQ16 −0.11 ± 0.06 −0.09 ± 0.07 −0.09 ± 0.04 
Data are mean ± SE, only individuals who completed intervention included. 
*: Indicates significant differences between groups, P ≤ 0.05. 
^: Indicates significant change over time (change different from zero), P ≤ 0.05. 
*, #: Like symbols indicated significant differences between groups, P ≤ 0.05. 
1Exercise time/week: Amount of time (min) spent exercising per week. 
2% Time in zone 3-5: Percentage of time exercising spent in HR zones 3, 4, or 5 (70%–100% HRR). 
3% Time in zone 1-2: Percentage of time exercising spent in HR zones 1 or 2 (50%–69% HRR). 
4ExEE/week: Exercise energy expenditure (in kcal) per week. 
5Kcal compensated/week: Energy (kcal) compensated for each week calculated by adding AEB + total 
ExEE together and dividing by 12. 
6Total exercise time: Total amount of time spent exercising during the entire 12-wk intervention (in min). 
7Total ExEE: Total exercise energy expenditure of the 12-wk intervention (in kcal). 
8Total kcal compensated: Total amount of kcal compensated, calculated by adding AEB + total ExEE 
together. 
9AEB: Accumulated energy balance, calculated from changes in bodily energy stores (changes in fat and 
lean mass) converted to kilocalorie equivalents. 
10CI: Percentage of kcal compensated for, calculated as (ExEE + AEB) / ExEE. 
11Kg weight loss: Kg of total body weight lost after the 12-wk intervention. 
12% weight loss: Kg of weight loss divided by baseline body weight (in kg). 
13Kg body fat loss: Kg of body fat lost after the 12-wk intervention. 
14% body fat loss: Kg of body fat loss divided by baseline body fat (in kg). 
15Delta REE/kg FFM: Changes in REE per kg of FFM from baseline to post (post value subtracted by 
baseline value). 
16Delta RQ: Changes in respiratory quotient during rest from baseline to post (post value subtracted by 
baseline value). 
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Table 8. Comparing pre- and post-prandial differences between groups and over time 
of the changes in AUC for concentrations of Leptin, Acylated Ghrelin, GLP-1, and 
Insulin. 
6-day per week group
N=12 
2-day per week group
N=14 
Control 
N=11 
Ghrelin ΔAUC −5321.99 ± 4304.09 1778.38 ± 2114.07 −4028.67 ± 2440.11
Leptin ΔAUC −998.57 ± 414.16 * # −604.53 ± 617.98 ^ 1118.31 ± 650.77 * ^ 
Insulin ∆AUC −1090.49 ± 759.40 410.80 ± 625.16 315.39 ± 1184.69 
GLP-11 ∆AUC −27.10 ± 20.85 −19.12 ± 22.86 −25.90 ± 12.85
Data as mean ± SE. 
*, ^: Like symbols indicated significant different between groups, P ≤ 0.05. 
#: Indicates significantly different from zero (change from baseline is significant), P ≤ 0.05. 
1GLP-1: Glucagon-Like Peptide 1
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Table 9. Regression models predicting CI among exercise groups. The control group 
did not have a value for ExEE and thus did not have values for CI. 
Effect β SE P Partial Correlation1 
Full model of all predictors 
Intercept 47.87 27.85 0.10 
Leptin2 ΔAUC 0.01 <0.01 <0.01 0.60 * 
Exercise frequency3 23.98 23.01 0.17 0.31 
Exercise time/week4 −0.13 0.11 0.24 −0.27
ExEE/week5 0.13 0.02 0.47 0.17 
% Time in zones 3–56 0.09 0.35 0.81 0.06 
% body fat lost7 5.79 1.25 <0.01 0.73 * 
Reduced model of significant predictors 
Intercept 86.42 7.05 <0.01 
Leptin2 ΔAUC 0.01 <0.01 <0.01 0.64 * 
% body fat lost7 4.28 0.88 <0.01 0.71 * 
1Partial correlation also displayed. 
*: Indicates significant correlation 
2Leptin ΔAUC: Changes in area under the curve for changes in concentrations of leptin pre-meal (fasting) 
to 2-hrs post-prandial. 
3Exercise frequency: Participants were randomly assigned to exercise 6-days per week or 2-days per 
week. 
4Exercise time/week: Amount of time (min) spent exercising per week. 
5ExEE/week: Exercise energy expenditure (in kcal) per week. 
6% Time in Zone 3-5: Percentage of time exercising spent in HR zones 3, 4, or 5 (70%–100% HRR). 
7% body fat loss: Kg of body fat loss divided by baseline body fat in kg. 
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Table 10. Regression models predicting percent body fat loss among exercise groups. 
The control group did not have values for many independent variables and predictors. 
Effect β SE P Partial Correlation1 
Full model of all predictors  
Intercept 5.62 4.78 0.26 
 
Leptin2 ΔAUC <0.01 <0.01 0.07 0.43 
Ghrelin3 ΔAUC <0.01 <0.01 0.03 0.50 * 
Exercise 
frequency4 
0.23 4.00 0.95 0.01 
Exercise 
time/week5 
0.02 0.02 0.22 0.29 
ExEE/week6 −0.01 0.03 0.05 −0.45 * 
% Time in zones 
3–57 
0.07 0.06 0.31 −0.25 
Reduced model of significant predictors  
Intercept 5.80 3.19 0.08 
 
Ghrelin3 ΔAUC <0.01 <0.01 <0.03 0.44 * 
ExEE/week6 −0.01 <0.01 0.01 −0.54 * 
1Partial correlation also displayed. 
*: Indicates significant correlation. 
2Leptin ΔAUC: Changes in area under the curve for changes in concentrations of leptin pre-meal (fasting) 
to 2-hrs post-prandial. 
3Ghrelin ΔAUC: Changes in area under the curve for changes in concentrations of leptin pre-meal 
(fasting) to 2-hrs post-prandial. 
4Exercise frequency: Participants were randomly assigned to exercise 6-days per week or 2-days per 
week. 
5Exercise time/week: Amount of time (min) spent exercising per week. 
6ExEE/week: Exercise energy expenditure (in kcal) per week. 
 
54 
CHAPTER 5. Discussion 
The present study evaluated aerobic exercise's effect at varying exercise 
frequencies on post-prandial hunger hormone responses after a 12-week exercise 
intervention. We evaluated the effect these hormonal changes have on the 
compensatory response to exercise and percent body fat loss change using a linear 
regression model to determine independent predictors of these hormonal changes. 
Determining these predictors can help reduce or slow the obesity epidemic by altering 
the way exercise intervention treatments are instituted. Recent research has indicated 
that exercise can alter appetite-regulating hormones; however, it is not known which 
variables predict these hormonal changes [2, 5, 8, 9]. Automatic compensatory 
responses to exercise can decrease the success of an exercise for weight loss 
intervention by resisting negative energy balance. These responses include decreases 
in resting and activity-induced energy expenditure [107, 108]. However, the primary 
compensatory response to an exercise-induced energy deficit is increased energy 
intake, controlled by the individual [1, 6, 19]. It is uncertain how appetite-regulating 
hormones affect energy compensation with exercise or other factors of the exercise 
program that influences these purported changes. From this evidence, we demonstrate 
the link between changes in appetite-regulating hormone concentrations, compensatory 
responses, and body fat change with exercise. 
One of the hypotheses proposed in the present study was that increases in ghrelin 
concentrations and decreases of leptin, insulin, and GLP-1 concentrations in response to 
a meal would be greater when exercising 6-days per week than 2-days per week for 12 
weeks did not hold. Only leptin was significantly different between groups, with the 6-day 
per week group decreasing to a greater extent than the 2-day per week group. This 
leptin change was most likely due to the 6-day per week group losing more body fat than 
the 2-day per week group. Many studies have demonstrated that leptin levels are 
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proportional to the degree of adiposity, with concentrations elevated among overweight 
and obese populations [8, 9]. However, since leptin is a satiety-inducing hormone, one 
may assume that greater increases in this hormone would reduce food consumption and 
improve the compensatory response to exercise. The present study demonstrated that 
greater leptin-delta AUC reductions predicted less energy compensation even when 
controlling for ExEE and body fat loss. Therefore, regardless of how much one exercises 
or how much fat one loses, the amount of leptin can predict the amount of kcal one 
compensates for in healthy and overweight to obese individuals. This may be due to 
exercise increasing leptin sensitivity, making it more effective as a satiety-inducing 
hormone. 
The other hypothesis proposed in the present study that changes in appetite-
regulating hormones after 12 weeks of exercise will predict body fat loss, with changes 
in ghrelin being negatively associated with body fat loss and leptin, GLP-1, and insulin 
being positively associated with body fat loss, only held with ghrelin. The present study 
observed changes in ghrelin-delta-AUC predicted percent body fat loss change even 
when controlling for CI and ExEE. Thus, greater increases in post-prandial ghrelin 
changes caused greater body fat loss, regardless of the length of exercise (ExEE) or the 
amount of kcal you compensate for (CI). 
This study is not without limitations. The exercise sessions that participants 
performed were unsupervised. Therefore, it was possible that additional exercise not 
being recorded, or not strictly aerobic exercise, was undertaken; nevertheless, no 
evidence led to this suspicion. Sex differences were not observed in the study likely due 
to the greater sample number of females. Regarding female participants, another 
limitation was not assessing the stage of the menstrual cycle. The menstrual cycle stage 
has been indicated in recent literature to alter energy intake and energy expenditure; 
thus, affecting compensatory response calculations made for certain subjects [64]. 
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CHAPTER 6. Conclusion 
Several studies have demonstrated changes in appetite-regulating hormones after 
acute- and long-term or moderate and intense exercise. However, the amount of 
research on changes in the hormones and their influence on compensatory response to 
exercise is limited [10-17, 21, 25-28]. This can pose limitations to health care 
professionals when prescribing the most effective exercise regimen in promoting 
sufficient weight loss among overweight and obese individuals. Based on the present 
study, understanding the influence of the appetite-regulating hormones on compensatory 
responses to exercise is essential for a successful weight loss intervention.  
From the results, leptin changes predict the amount of kcal one compensates for, 
regardless of the length of exercise or fat one loses. Being overweight and obese with a 
larger amount of FM than FFM diminishes the success of sufficient weight loss due to 
hormone imbalances that directly influence compensatory responses that can resist the 
maintenance of negative energy balance making weight loss a greater challenge [8, 9, 
21]. These leptin reductions caused less energy compensation, whereas reductions of 
ghrelin caused greater body fat loss; thus, analyzing leptin and ghrelin concentrations 
may be beneficial for weight loss success paired with exercise. One would think that 
reductions in leptin would cause greater energy compensation; however, we observed 
that reductions in leptin’s concentration caused less energy compensation. This leptin 
observation can be described by decreased leptin resistance due to reduced leptin 
concentration; thus, increasing leptin's receptors' sensitivity. Several research 
investigations have proposed many mechanisms that explain this phenomenon of leptin 
resistance [109]. The common conclusion of the mechanism that plays a vital role in 
leptin resistance is alterations in cellular Ob-Rb receptor signaling [109]. Leptin 
resistance is analogous to insulin resistance, in which physiological feedback 
mechanisms limit Ob-Rb receptor signaling in obese states; thus, reducing the appetite-
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regulating effects of leptin [109]. It is concluded that post-prandial changes in ghrelin and 
leptin are a crucial modulator in one’s success in an exercise for weight loss 
intervention, regardless of the length of exercises. Still, the physiological mechanisms 
that control compensatory responses are complex and could make it challenging to 
provide appropriate and effective treatment. The study's findings indicate the importance 
of the implications of these changes that can be a predictor for successful weight loss; 
however, future research is needed to evaluate the success of hormonal manipulation 
for sufficient weight loss among overweight and obese subjects.  
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